All conditions

Osteoarthritis

Plain English clinical trial information, updated daily from ClinicalTrials.gov and public government registries. Not medical advice.

4218
Trials on record
421
Recruiting now
7
Australian sites
21
Phase 3 trials
6
PBS medicines
How these figures are counted
  • Trials on record is every trial tagged to this condition at any stage, except those withdrawn before starting or terminated early. Most are completed rather than ongoing, so this is a measure of research history, not of current activity. It is also smaller than the sitewide "trials tracked" figure, which does include withdrawn and terminated trials.
  • Recruiting now counts only trials whose registry status is "Recruiting". Trials listed as not yet recruiting or enrolling by invitation are excluded, so this understates how many may open to new participants soon.
  • Australian sites counts trials counted under "Recruiting now" that list at least one Australian site. A site being listed does not mean it is currently enrolling, and Australian trials registered only on ANZCTR are not counted yet, so this understates local availability.
  • Phase 3 trials counts trials counted under "Recruiting now" that are at Phase 3.

Find recruiting trials for Osteoarthritis →

Get alerts when Osteoarthritis trials change ↗

Voxsanity currently covers 103 conditions. We are expanding coverage regularly.

Understanding Osteoarthritis

Osteoarthritis is a condition that affects the joints in your body. Joints are the places where two bones meet, such as your knees, hips, hands, and spine. Normally, the ends of those bones are covered by a smooth, rubbery layer called cartilage, which helps the joint move easily. In osteoarthritis, that cartilage gradually breaks down over time, which can cause pain, stiffness, and swelling in the affected joint. It can also make everyday movements, like walking or gripping objects, feel more difficult than they used to.

Osteoarthritis is actually very common in Australia. It affects around 2.1 million Australians, making it one of the most widespread chronic conditions in the country. It tends to become more common as people get older, and it affects more women than men. That said, it is not simply a normal part of ageing, and it can also occur in younger people, particularly those who have had a joint injury or who place repeated physical demands on their joints.

When it comes to managing osteoarthritis, doctors typically take a broad approach that looks at the whole picture. This often includes physical activity and exercise programs tailored to the individual, physiotherapy, maintaining a healthy weight, and pain management strategies. In some cases, aids like braces or walking devices can help take pressure off affected joints. For more severe cases where the joint has significantly deteriorated, surgical options such as joint replacement may be considered. A GP or specialist is the right person to talk to about what might be suitable for your individual situation.

This overview is an AI generated summary written from public medical sources and checked on a sample basis. It is general information, not medical advice or a diagnosis. Always speak with your doctor about your situation. How we use AI

Can you access treatment for Osteoarthritis in Australia right now? Here's what's publicly known.

Information on this site does not constitute medical advice. Data is sourced from publicly available government registries. Always consult your doctor before making any health decisions. Trial status should be verified directly with the trial site.

Updated regularly from public government registries

PBS-subsidised medicines for Osteoarthritis

6 medicines listed on the PBS for Osteoarthritis. Filter by authority type, or open the full table below.

What the authority types mean Unrestricted: no clinical criteria; a doctor can prescribe it on the PBS for any appropriate use. Restricted benefit: subsidised only for the specific conditions or uses set out by the PBS. Streamlined authority: restricted, but the doctor does not need prior approval; they record a streamlined authority code confirming you meet the criteria. Authority required: restricted, and the doctor must get prior approval from Services Australia (by phone or online) before it is subsidised. Source: Pharmaceutical Benefits Scheme (pbs.gov.au).
Full PBS medicines table 6 listed

These medicines are listed on the Pharmaceutical Benefits Scheme (PBS) for the specific indications shown. A listing does not mean a medicine is right for you; your doctor decides what is appropriate. Prices shown are the PBS-determined dispensed price. Most patients pay only the standard co-payment, up to AU$25.00 per script (general) or AU$7.70 (concession or Safety Net) in 2026, with the Australian Government subsidising the rest.

Medicine Brand(s) Listed for
Ibuprofen APO-Ibuprofen 400 arthropathies (including osteoarthritis) AU$2.5 Restricted benefit
Indometacin Arthrexin arthropathies (including osteoarthritis) AU$3.1 Restricted benefit
Naproxen Phebra Naproxen Suspension, Proxen SR 750, Proxen SR 1000 +2 more arthropathies (including osteoarthritis) AU$4.39 Streamlined authority
Piroxicam APO-Piroxicam arthropathies (including osteoarthritis) AU$2.96 Restricted benefit
Celecoxib Celebrex Osteoarthritis AU$4 Restricted benefit
Meloxicam CIPLA MELOXICAM 7.5, CIPLA MELOXICAM 15, Moxicam Osteoarthritis AU$3.1 Restricted benefit

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.

Research pipeline

Where trials for Osteoarthritis currently sit in the development pipeline. The funnel shape shows how few drugs reach later phases in general; the counts are this condition's actual trial numbers.

Phase success rates are industry-wide historical averages, not predictions for specific trials. Learn how trials work →

Most active research sponsors

Organisations with the most recruiting trials for Osteoarthritis.

View sponsor profile
View sponsor profile
View sponsor profile
View sponsor profile
View sponsor profile

Where trials are running

Clinical trial sites for Osteoarthritis by country. Australia is highlighted.

Showing the top 10 of 57 countries with trial sites.

Clinical trials for Osteoarthritis

Showing 424 of 424 trials

The plain English eligibility text on each trial below is an AI generated summary of the official criteria, checked on a sample basis. How we use AI

🇦🇺 NCT01066936 · Smith & Nephew, Inc. Not Applicable · 1 country Completed
Completed Not Applicable Est. completion 18 April 2016
🇦🇺 AU

Who might be able to join this trial: - You have a hip condition that means you need a total hip replacement surgery. - You are willing to give your consent to take part in the study. - You are able to stay involved for the full length of the study. - You are in generally stable health, and any heart, lung, blood, or o...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
🇦🇺 NCT05752032 · ICM Co. Ltd. Not Applicable · 1 country By Invitation
By Invitation Not Applicable Est. completion 1 December 2028
🇦🇺 AU

Who might be able to join this trial: - You must have previously taken part in a study where you received either the drug ICM-203 or a dummy treatment (placebo) that looked like ICM-203. Who may not be able to join: - There are no specific reasons listed that would prevent someone from joining this trial. Important:...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
🇦🇺 NCT04848896 · Smith & Nephew, Inc. Not Applicable · 4 countries Recruiting
Recruiting Not Applicable Est. completion 17 April 2026
🇦🇺 AU🇨🇳 CN Hong Kong🇳🇿 NZ

**Who might be able to join this trial:** - You are a suitable candidate for a total knee replacement surgery using a specific robotic surgical system (CORI) and a matching Smith+Nephew knee implant. - You need a cemented total knee replacement as your main treatment for one of the following: osteoarthritis or other n...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
🇦🇺 NCT05946044 · Wake Forest University Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 31 July 2029
🇦🇺 AU🇺🇸 US

**Who might be able to join this trial:** - People who are female - People with a Body Mass Index (BMI) of 30 or higher (this means a higher body weight relative to height) - People whose knee shows no signs of arthritis on both X-ray and MRI scans - People who have no knee pain, or knee pain on fewer than 15 days per...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
🇦🇺 NCT06191848 · University of Melbourne Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 May 2027
🇦🇺 AU

**Who might be able to join this trial:** - People with a body mass index (BMI) of 30 or higher (a measure of body weight relative to height that indicates obesity). - People who have tried and not succeeded in losing weight through lifestyle changes (such as diet and exercise) at least once before. - People who an or...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
🇦🇺 NCT06917404 · Paradigm Biopharmaceuticals Ltd. Phase 3 · 4 countries Recruiting
Recruiting Phase 3 Est. completion 1 July 2027
🇦🇺 AU Hong Kong Moldova🇺🇸 US

**Who might be able to join this trial:** - People who are 18 years of age or older at the time of signing the consent form - People who have been clinically diagnosed with osteoarthritis (OA) in the knee being studied, based on established medical criteria - People whose knee OA has been confirmed by X-ray (reviewed...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 NCT07338266 · Avidence Therapeutics Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 1 December 2026
🇦🇺 AU

**Who might be able to join this trial:** - People who are willing and able to give written consent, follow study instructions, and attend all required visits - People aged between 20 and 75 years (male or female) - People who have had knee osteoarthritis (OA) symptoms for at least 6 months before the screening appoin...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 NCT07509307 · Novo Nordisk A/S Phase 3 · 11 countries Recruiting
Recruiting Phase 3 Est. completion 14 August 2028
🇦🇺 AU🇧🇬 BG🇨🇦 CA🇩🇰 DK🇬🇷 GR🇮🇹 IT🇵🇱 PL Puerto Rico +3 more

**Who might be able to join this trial:** - People who were male or female at birth, aged 18 or older at the time of signing the consent form - People who have been clinically diagnosed with knee osteoarthritis and have confirmed changes visible on X-ray in the knee being studied (rated at a certain level of severity...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 NCT07532070 · University of Sydney Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 1 April 2028
🇦🇺 AU🇺🇸 US

Who might be able to join this trial: - People aged 18 or older who have ongoing lower back pain, have sought or seriously thought about seeking care from a doctor or specialist for it in the past 6 weeks, and find it at least moderately interferes with work or daily activities (including housework) - OR people aged 45...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
🇦🇺 NCT04864392 · Novartis Pharmaceuticals Phase 2 · 15 countries Terminated
Terminated Phase 2 Est. completion 29 September 2024
🇦🇷 AR🇦🇺 AU🇨🇦 CA🇨🇳 CN🇨🇿 CZ🇩🇰 DK🇪🇪 EE🇮🇳 IN +7 more

Who might be able to join this trial: - You are between 40 and 75 years old (male or female) - Your body weight falls within a certain range — specifically, your BMI (a measure of body weight relative to height) is below 40 - You have been diagnosed with knee osteoarthritis (wear-and-tear of the knee joint) in the main...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT00411060 · University of Florida Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 14 August 2026
🇺🇸 US

Who might be able to join this trial: - All patients who are seen at the UF&Shands Orthopaedics and Sports Medicine Institute and are willing to sign a consent form may be considered for participation. Who may not be able to join: - There are no stated exclusion criteria — all patients at this clinic who are intereste...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT01376024 · Columbia University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2027
🇺🇸 US

**Who might be able to join this trial:** - People who have painful arthritis at the base of the thumb (the joint where the thumb meets the wrist). - People who are able to understand and agree to take part in the study by giving their informed consent. **Who may not be able to join:** - People who are under 18 years...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02329093 · Shinshu University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2023
🇯🇵 JP

Who might be able to join this trial: - You have been diagnosed with osteoarthritis (wear and tear) of the hip joint - You are experiencing pain in your hip joint Who may not be able to join: - An X-ray shows a clear fracture (broken bone) in your hip joint Important: Always verify eligibility with the trial site dir...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02511158 · Fonds de Dotation pour la Recherche Clinique en Orthopédie et Patholog... Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2032
🇫🇷 FR

Who might be able to join this trial: - You have a tear in one or more of the ligaments in your knee - You have had surgery to repair or reconstruct the torn ligament(s), using any surgical method Who may not be able to join: - You do not wish to take part in the trial (participation must be your own choice) Importan...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02836262 · Hip Innovation Technology Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 25 August 2025
🇨🇦 CA

**Who might be able to join this trial:** - People who have a non-inflammatory degenerative joint disease affecting the hip — such as osteoarthritis, bone tissue death (avascular necrosis), arthritis caused by injury, certain hip growth conditions, hip fractures, or a specific bone growth disorder — and who need a fir...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02844738 · VivaTech International, Inc. Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 August 2026
🇺🇸 US

**Who might be able to join this trial:** - People who have been diagnosed with osteoarthritis, whether caused by natural wear and tear or a long-term injury. - People between 18 and 90 years of age. - People who are able to follow the treatment plan, attend lab tests, and take part in regular check-in interviews. - P...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT02844764 · VivaTech International, Inc. Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 August 2026
🇺🇸 US

**Who might be able to join this trial:** - People who have been diagnosed with osteoarthritis, whether from gradual wear and tear or a long-term injury. - People between 18 and 90 years of age. - People who are able to follow the treatment schedule, attend laboratory tests, and take part in regular check-in interview...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT02993029 · Xinhua Hospital, Shanghai Jiao Tong University School of Medicine Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2027
🇨🇳 CN

Who might be able to join this trial: - People who have osteoarthritis that causes pain. - People whose affected knee shows a specific level of bone activity (a measurement called SUV greater than 10) on a special type of bone scan using a substance called 18F-sodium fluoride. - People who are willing to take part volu...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03017118 · Massachusetts General Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇺🇸 US

**Who might be able to join this trial:** - You are 40 years of age or older - You can read, write, and speak English fluently - You are seeking medical care for pain at the base of your thumb - You have tenderness at the base of your thumb joint when examined by a doctor - A specific physical test on your thumb (invol...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03076658 · University of Colorado, Denver Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2031
🇺🇸 US

**Who might be able to join this trial:** - People between the ages of 21 and 85, both male and female, who have never had surgery on their spine. **Who may not be able to join:** - People who have previously had surgery on the spine or the nervous system running through it - People who have or have had cancer, whethe...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03168802 · Taipei Medical University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 25 November 2025
🇹🇼 TW

**Who might be able to join this trial:** - People aged between 20 and 79 years old, both men and women - People who have been diagnosed with lumbar vertebral facet joint syndrome (a condition causing lower back pain related to small joints in the spine) - People who have had lower back pain for at least six months, r...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03304730 · Hospital Israelita Albert Einstein Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇧🇷 BR

Who might be able to join this trial: - You must be older than 18 years old - You must speak Portuguese fluently or as your native language - You must have had low back pain (either constant or coming and going) for at least three months - Your back pain may or may not spread to your buttocks, and is made worse by bend...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03491761 · Endeavor Health Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 December 2025
🇺🇸 US

**Who might be able to join this trial:** - People who are able to give informed consent to participate in the study - People who have had chronic pain lasting more than 3 months - People whose knee X-ray (taken standing, with knees straight) shows a Grade 2 or 3 level of knee joint changes, based on a standard medical...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT03513731 · InGeneron, Inc. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇺🇸 US

**Who might be able to join this trial:** - Adults between 18 and 75 years of age (male or female) - People who have been diagnosed with osteoarthritis of the small joints in the lower spine (from the L1 to S1 region), as confirmed by a doctor involved in the trial - People who have had ongoing low back pain for at le...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03552705 · Stanford University Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 14 January 2027
🇺🇸 US

Who might be able to join this trial: - People aged between 18 and 30 years old - People who have injured the ACL (a ligament in the knee) in one knee within the last 4 days - People who have swelling or blood in the injured knee joint Who may not be able to join: - People who have inflammatory arthritis, significant...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT03663361 · Phillip Gribble Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2026
🇺🇸 US

**Who might be able to join this trial:** - People who are beginning rehabilitation for their first-ever acute lateral ankle sprain (mild, moderate, or severe) - People whose ankle sprain happened within 72 hours before joining the study - People whose ankle sprain was diagnosed by a doctor, medic, athletic trainer, ph...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03711773 · University of Missouri-Columbia Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2030
🇺🇸 US

Who might be able to join this trial: - People who are 18 years of age or older - People who are able to attend exercise or program classes three times per week for six months, with at least a 66% attendance rate (meaning no more than about one-third of classes can be missed) - People who are able to also attend standa...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03804853 · HealthPartners Institute Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇺🇸 US

**Who might be able to join this trial:** - You are older than 55 years of age. - You are scheduled to have a specific type of shoulder replacement surgery called a primary reverse total shoulder replacement (for the first time). - You are able to fill out questionnaires on your own. - You are willing and able to come...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03869996 · Istituto Ortopedico Rizzoli Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 October 2026
🇮🇹 IT

Who might be able to join this trial: - People who have knee osteoarthritis and are scheduled for a first-time full knee replacement surgery - People with a body mass index (a measure of body weight relative to height) below 32 - People who can complete a "Timed Up and Go" test (standing up from a chair, walking a shor...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03895489 · University of Alberta Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 3 April 2025
🇨🇦 CA

**Who might be able to join this trial:** - You have signed an approved consent form agreeing to take part in the study. - You are a man or a woman who is not pregnant, and you are between 50 and 75 years old at the time the device is implanted. - You have been diagnosed with a non-inflammatory degenerative joint disea...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03909139 · Massachusetts General Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2026
🇺🇸 US

Who might be able to join this trial: - People aged 18 or older - People experiencing symptoms that suggest a torn hip labrum (the ring of cartilage around the hip socket), such as catching, clicking, or popping sensations in the hip, pain when sitting, or pain when moving the hip in certain ways - People whose symptom...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03921944 · Milton S. Hershey Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2027
🇺🇸 US

Who might be able to join this trial: - People who are older than 45 years of age - People whose main diagnosis is osteoarthritis (wear-and-tear arthritis) of the shoulder - People whose total shoulder replacement surgery was performed by Dr. Armstrong - People who received a local anesthetic (numbing medication inject...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03949400 · University College of Northern Denmark Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 24 April 2020
🇩🇰 DK

Who might be able to join this trial: - People who have been referred to an exercise and education program because of knee osteoarthritis (a condition where the cartilage in the knee wears down) - People who are 18 years of age or older at the time of joining the trial - People who can read and understand Danish Who m...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03984461 · Dr. Grant M. Pagdin Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 December 2027
🇨🇦 CA

Who might be able to join this trial: - You must be able to give written consent and be willing and able to follow all of the study's requirements. - You must be male or female and at least 19 years old when you sign the consent form. - You must have a confirmed diagnosis of osteoarthritis in a major joint, shown by an...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT03991728 · AO Innovation Translation Center Not Applicable · 15 countries Recruiting
Recruiting Not Applicable Est. completion 1 September 2032
🇧🇷 BR🇨🇴 CO🇩🇰 DK🇩🇪 DE🇮🇳 IN🇳🇱 NL🇳🇿 NZ🇵🇰 PK +7 more

**Who might be able to join this trial:** - You are 18 years old or older - You need a total jaw joint (TMJ) replacement using an artificial implant - You are able to understand the study information and consent forms, are willing and able to follow the study requirements, and have signed a consent form approved by an...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04031820 · JointResearch Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2026
🇳🇱 NL

Who might be able to join this trial: - People who are scheduled for a planned (non-emergency) first-time hip replacement surgery using a cemented cup with a specific size liner (32mm or 36mm), for any medical reason - People whose hip replacement surgery will be performed using a specific surgical technique called the...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04049279 · JointResearch Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2026
🇳🇱 NL

**Who might be able to join this trial:** - People who are scheduled for a planned, first-time cemented total hip replacement surgery. - Men aged 70 or older, or women aged 65 or older. - People who are able and willing to follow study instructions and attend follow-up appointments. - People who understand what the stu...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04074863 · Ostfold Hospital Trust Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2029
🇳🇴 NO

Who might be able to join this trial: - People who have painful osteoarthritis in the joint at the base of the wrist where the two forearm bones meet (called the distal radioulnar joint) - People whose wrist joint in that area is considered stable (not prone to slipping out of place) Who may not be able to join: - Peo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04137835 · University of Colorado, Denver Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇺🇸 US

Who might be able to join this trial: - People who are generally healthy, with no known problems affecting the joint being studied in the trial. - People aged between 18 and 65 years old. - People who have given their agreement to participate in writing. - People who are able to understand and follow instructions throu...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04210284 · NYU Langone Health Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇺🇸 US

**Who might be able to join this trial:** - People who are scheduled for a planned (non-urgent) first-time total hip or total knee replacement surgery - People who are aged between 55 and 95 years old - People whose blood test results show signs of malnutrition, meaning at least one of the following: a serum albumin le...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04228419 · Ottawa Hospital Research Institute Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2030
🇨🇦 CA

**Who might be able to join this trial:** - You have shoulder arthritis (of unknown cause) and have tried non-surgical treatments for at least 6 months without enough relief from pain or difficulty moving your shoulder - Your non-surgical treatment must have included pain or anti-inflammatory medications, physiotherapy...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04260165 · Töölö Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2024
🇫🇮 FI

Who might be able to join this trial: - People who have a specific type of wrist arthritis known as SLAC (Scapholunate Advanced Collapse) or SNAC (Scaphoid Nonunion Advanced Collapse) at stage II or III, meaning moderate to advanced joint damage in the wrist. - People aged between 18 and 75 years old. - People who have...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04275362 · More Foundation Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 2 April 2023
🇺🇸 US

**Who might be able to join this trial:** *If you are a healthy volunteer (Control):* - You are 50 years of age or older. - You are willing to sign a consent form agreeing to have your walking movement recorded and analyzed. *If you have already had knee replacement surgery (Retrospective):* - You previously had a to...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04318041 · TRB Chemedica Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 31 December 2026
🇹🇭 TH

**Who might be able to join this trial:** - You are between 40 and 65 years old and have been diagnosed with primary osteoarthritis (OA) in the inner part of your knee joint - Your knee osteoarthritis has been rated as moderate in severity (Grade II or III on a standard medical scale) - The inward bowing of your knee...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT04364334 · UMC Utrecht Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2100
🇳🇱 NL

Who might be able to join this trial: - People who are receiving orthopaedic knee surgery or non-surgical knee treatment (such as advice, physiotherapy, or injections) at the UMC Utrecht. - People who are able to read and understand Dutch. - People who are willing and able to sign a broad consent form. Who may not be...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04427709 · Wake Forest University Health Sciences Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 December 2026
🇺🇸 US

**Who might be able to join this trial:** - You are between 19 and 74 years old, and your body weight falls within a healthy to moderately overweight range (BMI under 40) - You are generally in good health, as assessed by the lead doctor based on your medical history - If you are a healthy volunteer, your blood pressu...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT04449146 · University Hospital, Brest Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 August 2026
🇫🇷 FR

Who might be able to join this trial: - People aged 18 or older who have been informed about the study and agree in writing to take part - People who are scheduled to receive a reverse shoulder replacement on a shoulder joint that has not previously had an artificial implant Who may not be able to join: - People under...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04507412 · Christian Candrian Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 31 July 2032
🇨🇭 CH

**Who might be able to join this trial:** - People who are having a first-time shoulder replacement surgery on one shoulder (either a standard or reverse type of artificial shoulder joint) - People with a body mass index (a measure of body weight relative to height) between 18.5 and 35 - People who are able to give wri...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT04572256 · Austin V Stone Early Phase 1 · 1 country Recruiting
Recruiting Early Phase 1 Est. completion 1 June 2027
🇺🇸 US

Who might be able to join this trial: - People who are having their ACL (a knee ligament) reconstructed for the first time - People between the ages of 25 and 50 - People who also have an injury to the meniscus (the cartilage cushion in the knee) Who may not be able to join: - People who are having a repeat or revisio...

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.
NCT04580225 · University of Alberta Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2027
🇨🇦 CA

**Who might be able to join this trial:** - People who have a stage II or III wrist condition known as scapholunate advanced collapse (SLAC) or scaphoid nonunion advanced collapse (SNAC), and whose doctor has determined they are suitable for the surgical procedures included in this trial **Who may not be able to join:...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04676802 · Stanford University Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 February 2027
🇺🇸 US

Who might be able to join this trial: - People who are having surgery to remove a small wrist bone at the base of the thumb (called a trapeziectomy) to treat thumb arthritis - People who can read and communicate in English Who may not be able to join: - People who are currently pregnant - People who are currently taki...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT04688593 · Waldemar Link GmbH & Co. KG Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 1 January 2036
🇩🇪 DE🇬🇧 GB

Who might be able to join this trial: - People who are having a specific hip replacement device (the MobileLink acetabular cup system and a femoral stem, both made by Waldemar Link) implanted during their surgery - People who are 18 years of age or older - People who have read, understood, and signed the consent form a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04716803 · University of California, San Diego Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2023
🇺🇸 US

Who might be able to join this trial: - People whose knee X-rays show the most severe level of arthritis damage (grade IV on the Kellgren Lawrence scale) - People whose doctor or orthopaedic specialist has determined that a total knee replacement is needed - People who have ongoing knee pain that has not improved with...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04814082 · LifeBridge Health Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2030
🇺🇸 US

**Who might be able to join this trial:** - You are a man or a woman (not pregnant) between 18 and 75 years old - You are willing to sign a consent form agreeing to take part in the study - Your doctor has recommended you for a first-time total knee replacement using one of two specific knee implant systems: the MicroP...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04858347 · Waldemar Link GmbH & Co. KG Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2034
🇨🇴 CO

**Who might be able to join this trial:** - People who have given their written agreement to take part in the study - People who are receiving a specific type of knee replacement called a GEMINI SL Fixed Bearing PS knee prosthesis - People between 18 and 80 years of age **Who may not be able to join:** - People with a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04875052 · University of North Carolina, Chapel Hill Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2026
🇺🇸 US

**Who might be able to join this trial:** - People aged 16 to 35 years - People who have had a single ACL reconstruction surgery (on one knee only, for the first time), using a graft taken from their own patellar tendon and bone **Who may not be able to join:** - People who have previously torn their ACL or had a prev...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04901273 · Istituto Ortopedico Rizzoli Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2028
🇮🇹 IT

**Who might be able to join this trial:** - Only one knee is affected (not both knees at the same time) - You have signs and symptoms of wear-and-tear damage to the cartilage in your knee - An X-ray or MRI scan shows signs of cartilage degeneration in your knee, ranging from mild to severe - You are able and willing to...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04929951 · Stanford University Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 31 December 2027
🇺🇸 US

**Who might be able to join this trial:** - People between 25 and 75 years old - People who have already been diagnosed with osteoarthritis (joint wear and tear) in the shoulder joint (where the upper arm bone meets the shoulder socket) - People who can understand and communicate in English well enough to understand w...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT04937998 · Istituto Ortopedico Rizzoli Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2026
🇮🇹 IT

**Who might be able to join this trial:** - People aged between 30 and 65 years old - People who have pain or other symptoms of osteoarthritis specifically in the kneecap area (called patellofemoral osteoarthritis), in one or both knees - People whose knee X-rays or MRI scans show a specific level of kneecap joint dam...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04949087 · Rush University Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2027
🇺🇸 US

Who might be able to join this trial: - Adults aged 18 or older - People who have been diagnosed with primary shoulder joint arthritis (where the bones in the shoulder are rubbing together or nearly rubbing together), confirmed by X-ray and physical examination - People who have a baseline pain level greater than 4 out...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04960098 · I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2050
🇮🇹 IT

Who might be able to join this trial: - People aged 18 or older - People of any gender (male or female) - People who have had a hip or knee replacement surgery Who may not be able to join: - People under the age of 18 - People who have other health conditions that may make it difficult for them to return for follow-up...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04984291 · Zimmer Biomet Not Applicable · 3 countries Recruiting
Recruiting Not Applicable Est. completion 15 August 2033
🇯🇵 JP🇳🇿 NZ🇺🇸 US

**Who might be able to join this trial:** - You are 20 years of age or older. - Your shoulder's physical structure is suitable for receiving a shoulder replacement implant. - You need a shoulder replacement for one of these reasons: wear-and-tear arthritis or bone tissue death (avascular necrosis), rheumatoid arthriti...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04998188 · Istituto Ortopedico Rizzoli Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇮🇹 IT

**Who might be able to join this trial:** - People with knee cartilage degeneration affecting only one knee - People who have symptoms and physical signs of worn or damaged knee cartilage - People whose X-rays and MRI scans show signs of knee cartilage degeneration (graded on a standard scale from 1 to 4) - People who...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05020028 · NYU Langone Health Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 September 2027
🇺🇸 US

Who might be able to join this trial: - People who have been diagnosed with knee osteoarthritis at a moderate level (known as Kellgren-Lawrence Grade II or III) - People who have had knee pain for at least three months, with pain occurring on more than half of the days during that time - People whose pain scores at lea...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05062252 · Medacta International SA Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2026
🇨🇭 CH

**Who might be able to join this trial:** - People aged 18 years or older - People who have been medically advised to have an anatomic primary total shoulder replacement because of osteoarthritis and/or arthritis caused by a past injury - People who are willing and able to follow the study's requirements throughout the...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05067543 · Stryker Trauma and Extremities Not Applicable · 5 countries Recruiting
Recruiting Not Applicable Est. completion 30 June 2036
🇨🇦 CA🇫🇷 FR🇨🇭 CH🇬🇧 GB🇺🇸 US

**Who might be able to join this trial:** - You are 18 years old or older at the time of signing up for the study - You are willing and able to read and sign a consent form agreeing to take part - You are able and willing to follow all the steps and requirements of the study - Your doctor has decided that you are a sui...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05100966 · McMaster University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2026
🇨🇦 CA

Who might be able to join this trial: - You are aged 60 or older - You have been assessed as "pre-frail" or "frail" based on a standard frailty scoring system (scores 1–5 on this scale — confirm with trial site) - You are scheduled to have a planned hip or knee replacement surgery on one side of your body - Your estima...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05120492 · Nova Scotia Health Authority Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2027
🇨🇦 CA

Who might be able to join this trial: - People who have been diagnosed with severe knee osteoarthritis - People with a body mass index (BMI) between 45 and 60 Who may not be able to join: - People who have previously had a total knee replacement in the same knee - People who need both knees replaced at the same time -...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05211986 · Immunis, Inc. Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 30 March 2026
🇺🇸 US

**Who might be able to join this trial:** - People who have moderate knee osteoarthritis, specifically rated as Kellgren-Lawrence grade 2 or 3, in the affected knee - People who have weakness in the quadriceps muscles (the large muscles at the front of the thigh), measured below a certain threshold - People who are ab...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05254574 · ZetrOZ, Inc. Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 1 May 2026
🇺🇸 US

**Who might be able to join this trial:** - People who have been diagnosed by a doctor with mild to moderate osteoarthritis (also called Degenerative Joint Disease) in the knee, shoulder, elbow, ankle, hip, or spine, rated as early-stage on a standard medical scale (grades 1–2) - People whose knee osteoarthritis meets...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05292339 · Emory University Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 July 2027
🇺🇸 US

Who might be able to join this trial: - You are 18 years old or older - You have painful tendon or joint problems in your shoulder, elbow, hand, or wrist that are causing symptoms - You have not had surgery to treat your condition - Your condition may include trigger finger, De Quervain's tenosynovitis (a painful wrist...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT05351112 · Zimmer Biomet Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 21 January 2034
🇪🇸 ES

**Who might be able to join this trial:** - People who are 18 years or older and whose bones have finished growing - People who are able to understand the surgeon's explanations, follow instructions, and are willing to attend follow-up appointments and give consent to participate - People who are having a shoulder repl...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05357378 · Hip Innovation Technology Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 July 2026
🇺🇸 US

**Who might be able to join this trial:** - You need a first-time hip replacement on one side due to a non-inflammatory joint disease, such as osteoarthritis, bone tissue death (avascular necrosis), arthritis from a past injury, or certain hip conditions from childhood or injury. - You are between 50 and 75 years old a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05378841 · Assistance Publique - Hôpitaux de Paris Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 March 2026
🇫🇷 FR

**Who might be able to join this trial:** - Adults aged 18 or older - People diagnosed with symptomatic finger joint osteoarthritis, based on the criteria set by the American College of Rheumatology - People who have had pain of at least 4 out of 10 in one specific finger knuckle joint (a middle finger joint, known as...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05407610 · Ziekenhuis Oost-Limburg Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 1 March 2025
🇧🇪 BE🇳🇱 NL

**Who might be able to join this trial:** - People aged 18 or older. - People who have had ongoing front-of-knee pain for more than 12 months that is moderate to severe (a pain score above 4 out of 10 on most or all days, either all the time or when moving). - People whose knee pain has not been adequately relieved —...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05408065 · Centre hospitalier de l'Université de Montréal (CHUM) Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2026
🇨🇦 CA

**Who might be able to join this trial:** - People who have been diagnosed with moderate to severe primary shoulder osteoarthritis (stage II or higher, based on a classification system called Samilson-Prieto), confirmed by both physical examination and imaging. - People aged between 20 and 90 years. - People with osteo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05412615 · University of Colorado, Denver Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇺🇸 US

Who might be able to join this trial: - People who have wrist arthritis causing symptoms, linked to a specific type of wrist damage known as SLAC or SNAC (conditions where the bones in the wrist gradually wear down due to an old injury or ligament problem) - People who are between 30 and 80 years of age Who may not be...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05423587 · Varian, a Siemens Healthineers Company Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇬🇧 GB

**Who might be able to join this trial:** - People who are willing and able to give their consent to take part in the study - People aged 45 years or older - People who have knee osteoarthritis graded 1 to 3 on an X-ray (using a standard medical grading scale) - People who have had knee pain for at least 3 months that...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05484089 · Reinier Haga Orthopedisch Centrum Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2035
🇳🇱 NL

Who might be able to join this trial: - People who need a joint replacement in a finger's middle knuckle (called the PIP joint) due to painful osteoarthritis (joint wear and tear) or a severe, unstable broken bone at that joint - People who are older than 18 years of age - People who can speak and write in Dutch - Peop...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05487053 · Negovsky Reanimatology Research Institute Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇷🇺 RU

Who might be able to join this trial: - Adults aged 18 or older - People who are scheduled to have a first-time total knee replacement (not a repeat procedure) - People whose surgery is planned to use spinal or epidural anaesthesia (anaesthetic injected into the spine area) - People who have given written consent to ta...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05487274 · Ottawa Hospital Research Institute Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 March 2026
🇨🇦 CA

**Who might be able to join this trial:** - People who have been diagnosed with idiopathic shoulder osteoarthritis (wear-and-tear of the shoulder joint with no known cause) - People whose shoulder osteoarthritis has not improved after at least 6 months of non-surgical treatment, including pain medications, anti-inflamm...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05488093 · University Hospital, Montpellier Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2027
🇫🇷 FR

**Who might be able to join this trial:** - People who are over 60 years old - People who have osteoarthritis in one knee only, confirmed by imaging showing moderate to severe damage in the knee joint (confirm with trial site for exact staging details) - People whose knee pain has averaged more than 40 out of 100 on a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05495334 · Pacira Pharmaceuticals, Inc Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2032
🇺🇸 US

**Who might be able to join this trial:** - You are planning to receive treatment for knee pain caused by osteoarthritis — such as knee injections, nerve-blocking procedures, or knee replacement surgery — within 60 days of your screening visit - You are able to understand and fill out consent forms and questionnaires,...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05497349 · Istituto Ortopedico Rizzoli Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2026
🇮🇹 IT

**Who might be able to join this trial:** - People who have hip pain rated between 4 and 8 out of 10 on a pain scale, based on the past week - People who have imaging evidence of hip osteoarthritis, either on X-ray (early to moderate stage) or on MRI (showing early cartilage or joint rim changes, without recent injury...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05507099 · Grigory Karmy Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 8 August 2028
🇨🇦 CA

**Who might be able to join this trial:** - People aged 18 to 95 years old, of any gender - People who currently live in Canada - People who are willing and able to give written consent to take part in the study - People who are able and willing to follow the study procedures and attend scheduled phone check-ins - Peo...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05517434 · University Health Network, Toronto Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 June 2026
🇨🇦 CA

**Who might be able to join this trial:** - You are at least 30 years old - You are willing and able to follow the study schedule, attend visits, and understand instructions (spoken and written) - You are willing to sign a consent form to take part in the study - Your knee pain scores at least 4 out of 10 on a standard...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05543941 · Ottawa Hospital Research Institute Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 March 2027
🇨🇦 CA

**Who might be able to join this trial:** - Adults aged 18 or older, of any gender - People who have been diagnosed with osteoarthritis, inflammatory arthritis, bone tissue death (osteonecrosis), or arthritis caused by a past injury, in the affected joint - People who are having a first-time total knee replacement, to...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05547984 · Aesculap AG Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2027
🇨🇿 CZ

**Who might be able to join this trial:** - You have been diagnosed with hip joint wear and tear (osteoarthritis) and your doctor has recommended a hip replacement surgery using a type that does not use bone cement - You are willing and able to give written consent to take part in the study **Who may not be able to jo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05593640 · Centre Hospitalier Universitaire de Nice Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2023
🇫🇷 FR

**Who might be able to join this trial:** - People who have knee osteoarthritis with fluid build-up in the knee joint (known as an effusion), and who do not have an inflammatory disease **Who may not be able to join:** - People who are currently taking blood-thinning medications (anticoagulants) - People who have an i...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05596591 · Kessler Foundation Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇺🇸 US

**Who might be able to join this trial:** - People between 30 and 80 years old (inclusive) - People whose knee X-ray shows a level of arthritis graded 2 to 4 on a standard scale called the Kellgren-Lawrence scale - People who have a specific type of bone injury called a bone marrow lesion (BML), visible on an MRI scan...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05666167 · VA Office of Research and Development Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2026
🇺🇸 US

**Who might be able to join this trial:** - People who have been diagnosed with symptomatic osteoarthritis (a joint condition causing pain and stiffness) in the knee or hip - Veterans who receive care at Eastern Colorado Healthcare System Primary Care Clinics and have had at least one VA visit in the past year - People...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05675618 · Hospital for Special Surgery, New York Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇬🇧 GB🇺🇸 US

Who might be able to join this trial: - People who are 18 years of age or older - People who consider themselves a golfer (based on their own report) - People who are able to give their informed consent to take part in treatment - People who are scheduled for one of the following joint replacement or revision surgeries...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05686278 · Corin Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2028
🇫🇷 FR

**Who might be able to join this trial:** - People of any gender - Adults (18 years and older) - People who have been assessed by a doctor as medically suitable for a partial hip replacement (hemiarthroplasty) using Corin hip devices, for conditions such as: hip joint wear and tear (osteoarthritis), bone tissue death d...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05700682 · Palo Alto Veterans Institute for Research Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2026
🇺🇸 US

**Who might be able to join this trial:** **For the first part of the study (Diagnostic Arm):** - People who are Veterans and currently receive their healthcare through the VA system - People who have had ongoing pain in their shoulder, hip, or knee for at least one year - People whose painful joint shows mild to mode...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05734651 · Bezirkskrankenhaus St. Johann in Tirol Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 9 February 2026
🇦🇹 AT

Who might be able to join this trial: - You are having a first-time total hip replacement surgery using a specific implant called the PROMIS stem Who may not be able to join: - No specific exclusion criteria have been listed for this trial (confirm with trial site) Important: Always verify eligibility with the trial...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05761015 · University Hospital, Clermont-Ferrand Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 April 2028
🇫🇷 FR

**Who might be able to join this trial:** - People who have been diagnosed with osteoarthritis (wear-and-tear joint disease) in one or both hips or knees, confirmed by an X-ray showing a certain level of joint damage, where the condition has been causing pain for at least 3 months. - People who experience pain when wa...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT05800457 · London Health Sciences Centre Research Institute OR Lawson Research In... Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇨🇦 CA

Who might be able to join this trial: - People aged over 40 who have been diagnosed with knee osteoarthritis - People who are scheduled to have their first single-knee replacement surgery (on one knee only, for the first time) - People whose ultrasound results show moderate to severe inflammation and thickening of the...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05806021 · Centre hospitalier de l'Université de Montréal (CHUM) Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 December 2025
🇨🇦 CA

**Who might be able to join this trial:** - You have been experiencing pain or symptoms in one knee for more than 6 months, diagnosed as knee osteoarthritis according to standard medical guidelines - Your knee osteoarthritis has been graded as mild to moderate (Grade 1 to 3) on a standard X-ray scoring system - Your kn...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT05823727 · University of Arkansas Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2027
🇺🇸 US

Who might be able to join this trial: - People between 50 and 75 years old, of any sex - People with a body mass index (a measure of body weight relative to height) between 20.0 and 39.9 - People who have been diagnosed with primary osteoarthritis (joint damage caused by wear and tear, not another condition) - People w...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05839535 · Massachusetts General Hospital Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 30 March 2028
🇺🇸 US

Who might be able to join this trial: - People between 45 and 75 years of age - People who have been diagnosed with knee osteoarthritis in one or both knees for at least the past 3 months, based on recognised classification standards - People who are physically able to take part in a movement and stretching program - P...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05840887 · Istituto Ortopedico Rizzoli Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇮🇹 IT

**Who might be able to join this trial:** - People between 20 and 60 years of age, male or female - People diagnosed with osteoarthritis affecting one compartment of the knee joint, at a moderate or lower level of severity (Kellgren-Lawrence grade 3 or below) - People whose knee alignment is off by more than 5 degrees,...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05842538 · Sahlgrenska University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2025
🇸🇪 SE

**Who might be able to join this trial:** - You are scheduled for a planned (non-emergency) first-time knee replacement surgery due to severe osteoarthritis - You are suitable for a specific type of knee replacement that preserves certain ligaments in the knee (called a cruciate retaining replacement, using a "Triathlo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05848622 · University of North Carolina, Chapel Hill Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2027
🇺🇸 US

Who might be able to join this trial: - You have already finished all of your regular physical therapy sessions - You are between 16 and 35 years old - You had surgery to reconstruct your ACL (a ligament in the knee) between 6 and 60 months (up to 5 years) before joining the study - When you walk, your leg puts less fo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05868330 · Melinda Seering Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 October 2026
🇺🇸 US

**Who might be able to join this trial:** - People who are patients of an orthopedics service scheduled to have reverse shoulder replacement surgery - People classified as ASA physical status class I, II, or III — a standard medical rating of overall health (confirm with trial site) - People aged at least 18 years old...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT05887284 · University of Erlangen-Nürnberg Medical School Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2026
🇩🇪 DE

**Who might be able to join this trial:** - You have been diagnosed with osteoarthritis (joint wear and tear) in one of the following areas: fingers or wrists, elbow, shoulder, knee, or ankle and foot joints - You have never before received low-dose radiation therapy on the affected joint - You are willing to attend al...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05892133 · Molde University College Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇳🇴 NO

Who might be able to join this trial: - You have been diagnosed with knee arthritis (wear and tear of the knee joint) and have been referred for surgery. Who may not be able to join: - You have a cognitive disability or difficulties with thinking, memory, or understanding. - You have an inflammatory disease affecting...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05906433 · Foundation for Orthopaedic Research and Education Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 1 June 2025
🇺🇸 US

Who might be able to join this trial: - People who are 18 years of age or older and are able to give their own consent to participate. - People who have been diagnosed with primary osteoarthritis (a common form of joint wear and tear, not caused by another condition). - People whose osteoarthritis has been graded as St...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05912153 · Martini Hospital Groningen Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇳🇱 NL

Who might be able to join this trial: - People who are suspected to have symptomatic osteoarthritis (joint wear and tear) in the ankle, hindfoot, or midfoot area - People who give their written agreement to take part in the trial - People who are 18 years of age or older - People who have had an average pain level of 4...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05917028 · Next Biomedical Co., Ltd. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇰🇷 KR

**Who might be able to join this trial:** - You are 50 years of age or older (male or female) - You have been diagnosed with moderate knee osteoarthritis (a specific severity level called Kellgren-Lawrence grade 2 or 3), confirmed by an X-ray taken within the last 12 months - You have a pain level above 50 on a 100-poi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05933434 · Aarhus University Hospital Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 October 2030
🇩🇰 DK

**Who might be able to join this trial:** - People who have had ongoing knee pain for at least 6 months, with pain rated 4 or higher out of 10 at its worst - People diagnosed with moderate knee osteoarthritis (Grade II or III on a standard medical scale called the Kellgren Lawrence Classification) with a joint space of...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05936814 · Saglik Bilimleri Universitesi Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2023
Turkey (Türkiye)

Who might be able to join this trial: - People who are over 65 years of age - People who have knee osteoarthritis where the knee is bowed inward (a condition sometimes called "varus alignment") - People whose medical records and information are complete - People who have agreed to take part in the study Who may not be...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05980793 · Karolinska Institutet Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 July 2028
🇸🇪 SE

Who might be able to join this trial: - People who are 18 years of age or older - People who have ongoing, symptomatic osteoarthritis in a finger's middle knuckle joint (called the PIP joint) - People whose X-rays show signs of osteoarthritis in that joint, rated at a moderate to severe level using a standard medical g...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05986292 · Eli Lilly and Company Phase 2 · 2 countries Recruiting
Recruiting Phase 2 Est. completion 1 April 2027
Puerto Rico🇺🇸 US

**Who might be able to join this trial:** - People whose pain level falls between 40 and 95 on a standard pain rating scale (called a Visual Analog Scale) at the time of initial screening. - People who have experienced daily pain for at least 12 weeks, based on their own report or their medical records. - People who s...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05992883 · Mayo Clinic Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 31 December 2026
🇺🇸 US

**Who might be able to join this trial:** - Adults over 40 years of age - People who have pain at the base of the thumb that is triggered by pressure and movement - People whose thumb base pain has not improved with previous treatments such as over-the-counter pain relief (ibuprofen or acetaminophen), ice, splints or...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06003101 · Massachusetts General Hospital Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 30 August 2027
🇺🇸 US

Who might be able to join this trial: - People who are 18 years of age or older - People for whom a hip arthroscopy (a keyhole procedure to look inside the hip joint) has been recommended by the study's lead doctor to treat a problem with the labrum (the cartilage ring around the hip joint) - People who are willing to...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06010979 · Tian Hua Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇨🇳 CN

Who might be able to join this trial: - People who have primary osteoarthritis (wear-and-tear arthritis) in one knee - People who are having a knee replacement surgery on one knee only - People whose surgery uses one of the following approaches: traditional surgery, surgical robot, computer navigation, or a personalise...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06025448 · Lovisenberg Diakonale Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2033
🇳🇴 NO

Who might be able to join this trial: - People who are scheduled to have a primary reverse shoulder replacement surgery due to osteoarthritis, a large rotator cuff tear, a failed rotator cuff repair, or shoulder instability that has led to arthritis - People whose shoulder socket bone has significantly shifted inward (...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06034262 · TBF Genie Tissulaire Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 January 2026
🇫🇷 FR

**Who might be able to join this trial:** - People aged between 18 and 75 years, of any gender - People who have osteoarthritis causing symptoms in the middle joint of a finger (the proximal interphalangeal joint) - People who have been receiving medical treatment for functional symptoms for more than 3 months with no...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06038331 · TBF Genie Tissulaire Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 December 2026
🇫🇷 FR

**Who might be able to join this trial:** - You are a man or woman between 18 and 75 years old. - You have been diagnosed with a painful condition affecting a specific joint in your wrist called the STT joint (where three small wrist bones meet). - You have been receiving medical treatment for your wrist symptoms for m...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06040827 · Canary Medical Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2028
🇺🇸 US

**Who might be able to join this trial:** - People who are 18 years of age or older - People whose doctor has determined they are a suitable candidate for a total knee replacement based on a physical examination and medical history, including a diagnosis of severe knee pain and difficulty moving due to osteoarthritis...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06040957 · Istituto Ortopedico Rizzoli Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2027
🇮🇹 IT

**Who might be able to join this trial:** - Adults between 40 and 75 years old (men or women) - People who have pain or swelling in one knee due to osteoarthritis for at least 6 months - People whose knee osteoarthritis has been confirmed by X-ray - People who have already tried non-surgical treatments for at least 4 m...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06054633 · Xiangya Hospital of Central South University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2025
🇨🇳 CN

**Who might be able to join this trial:** - People aged between 40 and 80 years old - People who have been diagnosed with knee osteoarthritis according to recognised clinical guidelines - People who have had knee pain for 3 months or longer, with pain rated at a moderate-to-high level on a standard osteoarthritis pain...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06058169 · Augusta University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇺🇸 US

Who might be able to join this trial: - People who have had painful knee osteoarthritis symptoms for at least 6 months - Both men and women may be considered - People between the ages of 40 and 75 years old Who may not be able to join: - People younger than 40 or older than 75 years old - People with a history of bala...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06075004 · University of Chile Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 October 2025
🇨🇱 CL

**Who might be able to join this trial:** - You have been rated by an anesthesiologist as being in generally good to moderate health before surgery (this is called ASA classification 1–3; confirm with trial site if unsure which category applies to you) - Your body mass index (BMI) — a measure based on your height and w...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06077942 · FX Shoulder Solutions Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2032
🇺🇸 US

Who might be able to join this trial: - You had a shoulder replacement surgery using an FX Shoulder Solutions device, and your surgeon decided it was the right treatment for you, with the surgery taking place between January 1, 2018 and June 30, 2023. Who may not be able to join: - You did not have a shoulder replacem...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06078189 · Clinique Bizet Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2026
🇫🇷 FR

**Who might be able to join this trial:** - People who are older than 45 years of age - People who have painful thumb base joint arthritis (where the thumb meets the wrist) that has not improved after wearing a night splint for 3 months and at least 2 joint injections in a year - People who have been informed about the...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06078865 · FX Shoulder Solutions Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2031
🇺🇸 US

"Who might be able to join this trial: - People who are having an FX shoulder replacement device implanted, where the device is being used for the medical purposes it is approved and intended for. Who may not be able to join: - People who do not meet the inclusion criterion described above. Important: Always verify e...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06083480 · Vanderbilt University Medical Center Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 September 2028
🇺🇸 US

**Who might be able to join this trial:** - People aged 50 or older - People whose thinking and memory are assessed as sufficiently intact to understand and agree to take part in the study (checked using a standard mental status screening test) - People who can read and write in English well enough to understand and c...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06084364 · Diakonhjemmet Hospital Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 January 2027
🇳🇴 NO

**Who might be able to join this trial:** - You are between 40 and 85 years old (male or female) - You have been diagnosed with osteoarthritis (a type of joint wear and tear) in the joint at the base of your thumb, confirmed by an X-ray or ultrasound - An ultrasound has shown inflammation in that thumb joint - You have...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06088160 · Western University, Canada Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2025
🇨🇦 CA

Who might be able to join this trial: - You are 60 years of age or older and are scheduled to have a planned hip replacement surgery on one hip for arthritis - You are able to walk at least 10 meters (about 33 feet) on your own, with or without a walking aid such as a cane or walker, but without needing another person...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06090097 · Barron Associates, Inc. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2026
🇺🇸 US

Who might be able to join this trial: - People who have been diagnosed with osteoarthritis through an X-ray, with a severity score of at least 2 out of 4 on a standard medical grading scale for osteoarthritis - People who are able to walk on their own without needing a walking aid such as a cane, walker, or crutches W...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06094660 · Dijklander Ziekenhuis Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2026
🇳🇱 NL

**Who might be able to join this trial:** - Adults of any sex, aged over 35, who are not suitable candidates for total knee replacement surgery due to age (too young or too old), other health conditions, or technical reasons related to their anatomy or situation - People who score below 30 on the Oxford Knee Score (OKS...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06096259 · Brigham and Women's Hospital Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 December 2028
🇺🇸 US

**Who might be able to join this trial:** - People aged 25 to 45 with an ACL (knee ligament) injury who are planning to have ACL reconstruction surgery within 12 months of their injury - People aged 18 to 24 with an ACL injury who scored below 80 on a knee pain scale (called the KOOS Pain score, where 100 is the best p...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06105788 · University of Texas, El Paso Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 16 October 2025
🇺🇸 US

**Who might be able to join this trial:** **For people with knee osteoarthritis (target: 40 participants):** - People aged 45 or older - People who experience knee pain that is brought on or made worse by activity - People whose morning knee stiffness either does not occur or lasts no longer than 30 minutes - People w...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06118892 · Moximed Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2030
🇺🇸 US

Who might be able to join this trial: - You are between 25 and 65 years old at the time of the procedure - Your Body Mass Index (BMI) is under 35 (a measure of body weight relative to height) - You have knee pain that gets worse with activity and is focused specifically on the inner side of the knee, not the whole knee...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06122727 · Istituto Ortopedico Rizzoli Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2026
🇮🇹 IT

Who might be able to join this trial: - People aged 40 to 70 years (inclusive) who are being considered for a primary cemented total knee replacement surgery. - People who are willing to participate and are able to attend the required study visits and follow-up appointments. - People who have signed the consent form th...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06127719 · Dijklander Ziekenhuis Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇳🇱 NL

Who might be able to join this trial: - People who are currently on a waiting list for a partial or total knee replacement surgery - People who are able and willing to provide written consent to participate Who may not be able to join: - There are no listed exclusion criteria for this trial Important: Always verify e...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06142669 · MicroPort Orthopedics Inc. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2036
🇮🇹 IT

**Who might be able to join this trial:** - People who have already had, or have been scheduled to have, a revision knee replacement surgery using the specific implant components being studied (EVOLUTION® Revision Tibial System and EVOLUTION® STEMMED CS Femur with the EVOLUTION® MP CS Tibial Insert) - The decision to u...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06148779 · Joint Academy Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2025
🇸🇪 SE

**Who might be able to join this trial:** - People who are already registered in the Joint Academy database and have previously taken part in the Joint Academy treatment program for osteoarthritis (a joint condition causing pain and stiffness), and who agreed to have their data used for research. - People who have been...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06158646 · Clinique du Sport, Bordeaux Mérignac Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 August 2027
🇫🇷 FR

**Who might be able to join this trial:** - People who are attending a follow-up consultation 1 year after having a total knee replacement - People who are adults (18 years or older) - People who are enrolled in a social security (health insurance) system - People who have been fully informed about the study and have s...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06163573 · University Hospital, Basel, Switzerland Phase 2 · 3 countries Recruiting
Recruiting Phase 2 Est. completion 1 September 2028
🇭🇷 HR🇩🇪 DE🇨🇭 CH

**Who might be able to join this trial:** - People aged 18 to 65 years old at the time of screening. - People who have been diagnosed with patellofemoral osteoarthritis (a type of knee joint wear affecting the kneecap area) rated as grade 1 to 3 on the Iwano Classification scale. - People who have cartilage damage rat...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06166628 · David Clinkard Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇨🇦 CA

**Who might be able to join this trial:** - People who are over 40 years old - People who are able to give informed consent (agree to participate after being fully informed) - People who have had knee pain caused by osteoarthritis for at least 6 months - People whose knee pain has not improved enough with treatments su...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06171204 · University Hospital, Ghent Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇧🇪 BE

Who might be able to join this trial: - People who are legally able to make their own decisions and give consent - People who have damage to both the cartilage and bone in a joint (osteochondral lesions) - People who have pain and swelling in a joint caused by inflammation - People who have inflammation around a tendon...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06173713 · Canadian Radiostereometric Analysis Network Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 August 2027
🇨🇦 CA

Who might be able to join this trial: - People who need their first total hip replacement due to severe hip pain or disability caused by osteoarthritis, rheumatoid arthritis, arthritis from an old injury, a hip joint that didn't form properly, bone death in the hip (AVN), or a recent hip fracture. - People who are able...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06184451 · University of Nove de Julho Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2026
🇧🇷 BR

Who might be able to join this trial: - People who have been clinically diagnosed with osteoarthritis in one knee only (not both knees) - People who have been experiencing knee pain for more than three months - People whose knee stiffness in the morning lasts less than 30 minutes - People whose affected knee shows a cr...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06187038 · University of Nove de Julho Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 November 2026
🇧🇷 BR

**Who might be able to join this trial:** - You have been diagnosed with knee osteoarthritis, with knee pain that has lasted more than 3 months - You experience morning stiffness in your knee that lasts less than 30 minutes - You have a crackling or grinding sensation in your knee (sometimes called "crepitus") - You ha...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06193057 · Istituto Ortopedico Rizzoli Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 April 2026
🇮🇹 IT

**Who might be able to join this trial:** - You are a man or woman between 40 and 75 years old (inclusive) with arthritis in one ankle joint, and your doctor has recommended you for a first-time total ankle replacement surgery. - You are willing and able to attend all required study appointments and follow-up visits. -...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06193343 · University of Georgia Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 January 2028
🇺🇸 US

**Who might be able to join this trial:** - People who have signed and dated a consent form to take part in the study (for children, both a signed assent from the child and a permission form from a parent or guardian are required) - People who had anterior cruciate ligament reconstruction (knee surgery to repair a tor...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06195423 · University of British Columbia Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2026
🇨🇦 CA

**Who might be able to join this trial:** - People who currently live in British Columbia, Canada - People who are between 16 and 35 years old (inclusive) - People who are 9 to 36 months past their first ACL reconstruction surgery, where that surgery happened within 12 months of their first ACL tear - People who are n...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06196567 · Chinese University of Hong Kong Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
Hong Kong

Who might be able to join this trial: - People over 50 years old (male or female) who have severe, end-stage knee arthritis and are waiting for a total knee replacement surgery - People who have already been scheduled for a total knee replacement at Prince of Wales Hospital - People who are able to take part in all stu...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06221709 · University of Brasilia Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 August 2026
🇧🇷 BR

**Who might be able to join this trial:** - People who are 18 years of age or older - People who have been diagnosed with osteoarthritis in one hip, rated as grade II or III on a standard medical scale used to measure joint damage (confirm with trial site if unsure of your grading) - People who have had hip pain for mo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06228573 · McMaster University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 September 2025
🇨🇦 CA

Who might be able to join this trial: - People who live independently in the community in Sherbrooke (Quebec) or Hamilton or London (Ontario) - People aged 45 or older - People who have been diagnosed with knee osteoarthritis, OR who have knee pain that occurs with movement, with either no morning knee stiffness or mor...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06237153 · Marie Badalamente Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 31 December 2025
🇺🇸 US

Who might be able to join this trial: - People who are male or female and older than 18 years of age. - People who have been diagnosed with thumb base (CMC) joint arthritis at stage I, II, or III, confirmed by X-ray. - People whose thumb pain is rated 5 or higher on a standard 10-point pain scale. - People who are will...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06251167 · University of British Columbia Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 10 April 2027
🇨🇦 CA

**Who might be able to join this trial:** - People who have been diagnosed with osteoarthritis on the inner side of the knee joint, confirmed by X-ray showing bone spurs and narrowing of the joint space. - People who have had knee pain for more than 6 months. - People whose average knee pain over the past 6 months has...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06251752 · Istituto Ortopedico Rizzoli Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇮🇹 IT

Who might be able to join this trial: - People who have been diagnosed with osteoarthritis affecting the inner side of one knee, rated as moderate to severe (grade 3 or 4 on a standard medical scale) - People who have had at least 60 months (5 years) of follow-up care after their knee surgery - People whose medical rec...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06258369 · Lille Catholic University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 19 August 2027
🇫🇷 FR

**Who might be able to join this trial:** - Adults aged 18 or older - People who have been diagnosed with primary hip osteoarthritis (wear and tear of the hip joint) at any stage - People attending the orthopaedic department at a participating hospital, either in preparation for hip replacement surgery or for a consult...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06264076 · Oslo University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇳🇴 NO

Who might be able to join this trial: - You are a man or woman aged 41 or older who needs a total knee replacement surgery - Your knee condition is caused by natural wear and tear (osteoarthritis) or by bone tissue dying due to loss of blood supply (osteonecrosis) - You are generally in good health with no major health...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06267482 · London Health Sciences Centre Research Institute OR Lawson Research In... Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 December 2025
🇨🇦 CA

Who might be able to join this trial: - People who have painful knee osteoarthritis that has been assessed as needing a full knee replacement - People whose knee bends inward (a "bow-legged" alignment) by no more than 10 degrees - People whose knee ligaments, specifically the ligament at the back of the knee (posterior...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06272825 · Kirsehir Ahi Evran Universitesi Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 14 December 2024
Turkey (Türkiye)

Who might be able to join this trial: - People aged between 40 and 85 years old who have been diagnosed with knee osteoarthritis lasting more than 3 months - People whose knee X-ray shows a Kellgren and Lawrence Score of 2 or higher (a measure of joint damage visible on imaging — confirm with trial site if unsure of yo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06280352 · Austrian Workers Compensation Board Styria Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2027
🇦🇹 AT

Who might be able to join this trial: - You are a man or a woman who is not pregnant, between the ages of 40 and 90 years old - You need a full knee replacement for the first time (not a revision or repeat procedure) - Your surgeon has determined that a type of knee replacement that keeps a certain ligament in the knee...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06290336 · Linkoeping University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2027
🇸🇪 SE

Who might be able to join this trial: - People who are on a waiting list for their first knee replacement surgery on one knee - People whose main reason for needing knee surgery is osteoarthritis of the knee - People who live within 60 minutes of travel to the location where the trial is being run Who may not be able...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06292169 · Emory University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2026
🇺🇸 US

Who might be able to join this trial: - People who are scheduled to have a type of shoulder replacement surgery called a reverse total shoulder arthroplasty (a surgery where an artificial shoulder joint is placed in a reversed position compared to the natural joint) - People who are willing and able to give their infor...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06298721 · The Cleveland Clinic Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2027
🇺🇸 US

Who might be able to join this trial: - Adults between 19 and 79 years of age - People who are proficient in English - People who are willing to sign a consent form agreeing to take part in the study - People who are scheduled to have a single knee replacement on one knee only (not both at the same time) - People whose...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06311513 · Hospital for Special Surgery, New York Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 December 2027
🇺🇸 US

**Who might be able to join this trial:** - People who are male or female, aged between 18 and 55 years old - People who have previously had a reconstruction of the ACL (a ligament in the knee) on one knee within the last 5 years, where that surgery did not succeed as expected - People who are already scheduled to have...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06312943 · Assistance Publique - Hôpitaux de Paris Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2029
🇫🇷 FR

Who might be able to join this trial: - People aged 18 years or older - People with inflammatory or non-inflammatory bone and joint diseases that require either fluid to be drained from a joint or joint replacement surgery - People who have agreed to participate (non-opposition collected) - People who are affiliated wi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06319911 · Smith & Nephew, Inc. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 August 2027
🇺🇸 US

**Who might be able to join this trial:** - People who are 18 years of age or older and have reached full bone maturity - People who are scheduled for their first (not repeat) planned shoulder replacement surgery — either a standard (anatomic) or reverse type - The shoulder replacement must be for one of these reasons...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06323018 · University of Tartu Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2026
🇪🇪 EE

Who might be able to join this trial: - People who are older than 65 years of age - People who are scheduled to have a cemented total hip replacement surgery Who may not be able to join: - People who have already been diagnosed with peripheral artery disease (a condition affecting blood flow in the arteries) in both a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06328062 · Thammasat University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2025
🇹🇭 TH

Who might be able to join this trial: - People between 50 and 85 years old - People who have osteoarthritis in one knee (not both) and are scheduled for their first total knee replacement surgery on that knee - People whose overall health before surgery falls within a certain accepted range, as assessed by their medica...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06357741 · Union Hospital, Tongji Medical College, Huazhong University of Science... Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇨🇳 CN

**Who might be able to join this trial:** - People who have been diagnosed with knee osteoarthritis, based on the official diagnostic criteria for arthritis - People who have no known allergies or medical reasons that would prevent them from taking the trial medications - People who are between 45 and 75 years old - Pe...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06359301 · Limacorporate S.p.a Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2028
🇵🇱 PL

**Who might be able to join this trial:** - A doctor has already decided — separately from this study — that you need a total hip replacement using a specific implant called the DELTA Revision acetabular cup, as part of your normal medical care - You are 18 years old or older - You are willing and able to sign a writte...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06367283 · Marius Henriksen Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 December 2025
🇩🇰 DK

Who might be able to join this trial: - People aged 18 years or older - People who have been diagnosed with hand osteoarthritis based on established medical criteria - People who have had an average finger pain level of 4 or more out of 10 (where 10 is the worst pain) across fingers 2 to 5, over the past 30 days - Peop...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06370312 · Region Skane Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 April 2026
🇸🇪 SE

Who might be able to join this trial: - Adults aged 25 years or older, of any gender - People who have been diagnosed with thumb base joint osteoarthritis (confirmed by imaging), are experiencing symptoms from it, and are already planned to have a surgical procedure called a trapeziectomy to treat it Who may not be ab...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06376422 · Sven Behrendt Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 April 2029
🇩🇪 DE

**Who might be able to join this trial:** - People (male or female) who have lost part of their outer knee cartilage pad (lateral meniscus) and have pain on the outer side of the knee joint, OR who have lost part of their inner knee cartilage pad (medial meniscus) and have pain on the inner side of the knee joint - Pe...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06381791 · The Methodist Hospital Research Institute Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 30 December 2026
🇺🇸 US

Who might be able to join this trial: - People who are 18 years of age or older - People who are scheduled to have rotator cuff repair surgery - People who will be receiving standard anaesthesia during their surgery - People who are capable of having children must be using effective contraception for one month before,...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06383936 · Istituto Ortopedico Rizzoli Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇮🇹 IT

Who might be able to join this trial: - People between 40 and 65 years old. - Both men and women are eligible. - People who were physically active in sports before a knee problem stopped them from continuing — specifically, those who score a 3 or 4 on a standard physical activity scale called the "Saltin-Grimby Physica...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06384898 · Tufts Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇺🇸 US

**Who might be able to join this trial:** - You are 50 years of age or older - A doctor has diagnosed you with knee osteoarthritis - You have a moderate-to-high level of knee pain, based on a specific pain questionnaire score (confirm with trial site) - You are able to give your informed consent to participate - If pla...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06385275 · Boston University Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 December 2026
🇺🇸 US

Who might be able to join this trial: - People who are 60 years of age or older - People who have been diagnosed with knee osteoarthritis by a rheumatologist - People who are fluent in English Who may not be able to join: - People who take blood-thinning medications, including warfarin, dabigatran, rivaroxaban, or api...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06388811 · Istanbul University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 19 March 2025
Turkey (Türkiye)

**Who might be able to join this trial:** **Patient group (people with early knee symptoms):** - People who meet specific diagnostic criteria for early-stage knee osteoarthritis, based on a combination of symptoms (such as pain when going up and down stairs or pain that gets worse with activity) and risk factors (conf...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06389435 · Danderyd Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2027
🇸🇪 SE

**Who might be able to join this trial:** - Adults who are 18 years of age or older - People who have been assessed as suitable for a total knee replacement based on local medical guidelines and standard practice - People who are willing to take part in the study **Who may not be able to join:** - People whose knee al...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06391554 · University of Aarhus Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2027
🇩🇰 DK

**Who might be able to join this trial:** - People who have been clinically diagnosed with hip osteoarthritis (a condition where the hip joint wears down over time) according to specific guidelines from a UK health authority called NICE - People whose hip osteoarthritis diagnosis has been confirmed by an X-ray showing...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06401317 · Université du Québec à Trois-Rivières Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 31 December 2027
🇨🇦 CA

**Who might be able to join this trial:** - People aged 18 years or older - People who have been diagnosed with thumb base joint arthritis (TMO), confirmed by an X-ray reviewed by a radiologist - People who are experiencing pain at the base of the thumb - People whose attending doctor has decided that a corticosteroid...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06407427 · Yale University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2026
🇺🇸 US

**Who might be able to join this trial:** - People who are willing to sign and date a consent form agreeing to take part in the study - People who are willing to follow all study procedures and are available for the full length of the study - People who can read and speak English - People who have recently had a low-e...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06414473 · University of Florida Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 31 December 2026
🇺🇸 US

**Who might be able to join this trial:** - People who have been diagnosed with knee osteoarthritis (a condition where the cartilage in the knee breaks down over time) - People who experience moderate to severe knee pain (rated 4 out of 10 or higher) during physical activity, in one or both knees **Who may not be able...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06423300 · ZKR Orthopedics Inc Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2027
🇺🇸 US

**Who might be able to join this trial:** - People who are between 22 and 65 years old at the time of screening - People who have pain at the front of the knee caused by cartilage breakdown behind the kneecap, confirmed by MRI to be at a moderate-to-severe level (Modified Outerbridge score of 3 or higher) - People with...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06423716 · Sunnybrook Health Sciences Centre Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 July 2026
🇨🇦 CA

**Who might be able to join this trial:** - People aged 50 or older - People who have been diagnosed with knee osteoarthritis - People who are scheduled for a planned, non-emergency knee replacement surgery on one knee - People whose overall health status falls within a certain acceptable range for surgery (confirm wi...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06442319 · Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszc... Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 April 2028
🇵🇱 PL

Who might be able to join this trial: - People who are between 18 and 45 years old - People with a body mass index (a measure of body weight relative to height) below 40 - People who have had an ACL (knee ligament) reconstruction surgery - People who have small meniscal (knee cartilage) lesions that are not causing sym...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06451120 · University of California, San Francisco Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 16 February 2027
🇺🇸 US

Who might be able to join this trial: - People with knee osteoarthritis that has been rated as Grade 1, 2, or 3 on a standard medical scale (called the Kellgren-Lawrence scale) - People who have had knee osteoarthritis symptoms in one knee for at least 3 months before visiting the trial site - People whose osteoarthrit...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06451510 · Umeå University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇸🇪 SE

Who might be able to join this trial: - People from the Norrbotten region in northern Sweden who had a tibial plateau fracture (a break in the upper part of the shinbone where it meets the knee) between 2001 and 2015 Who may not be able to join: - People who have passed away without having had weight-bearing knee X-ra...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06462625 · Istituto Ortopedico Rizzoli Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2024
🇮🇹 IT

**Who might be able to join this trial:** - People who are having corrective knee bone surgery, and possibly related procedures such as meniscus repair or removal, ligament repair, cartilage treatment, or regenerative injections - People who are between 18 and 70 years old at the time of surgery - People who have arthr...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06463847 · Union Hospital, Tongji Medical College, Huazhong University of Science... Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 30 October 2024
🇨🇳 CN

**Who might be able to join this trial:** - A person must give written consent before any assessments take place - The person must be able to communicate clearly with researchers and follow the study requirements throughout - The person must be between 50 and 70 years old (inclusive), of any gender - Men must weigh at...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06466850 · Isfahan University of Medical Sciences Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 25 December 2026
Iran

**Who might be able to join this trial:** - People who have had ongoing knee joint pain for at least 3 months. - People whose body mass index (BMI) falls between 21.5 and 29.5 (a measure of body weight relative to height). - People who have knee osteoarthritis confirmed by X-ray, rated as mild to moderate severity (gra...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06477965 · Vascular Solutions of North Carolina Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 July 2027
🇺🇸 US

Who might be able to join this trial: - People over 18 years old who have had an artery-blocking procedure (called embolization) to treat long-term pain caused by osteoarthritis or another condition that causes pain in a specific area of the body. Who may not be able to join: - No specific exclusion criteria have been...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06478186 · University of Kansas Medical Center Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 16 December 2026
🇺🇸 US

**Who might be able to join this trial:** - People who are willing and able to give written consent and follow all study procedures and schedules. - People aged 40 years or older (male or female). - Females who have a negative pregnancy test, are not breastfeeding, and do not plan to become pregnant from the screening...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06483269 · Istituto Ortopedico Rizzoli Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2026
🇮🇹 IT

**Who might be able to join this trial:** - People of any sex between 18 and 40 years old with knee osteoarthritis that is causing symptoms - Only one knee is affected (not both) - There are signs and symptoms of knee osteoarthritis present - Imaging (X-ray or MRI) shows signs of cartilage damage in the knee, graded be...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06488144 · VA Office of Research and Development Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 31 May 2029
🇺🇸 US

Who might be able to join this trial: - People who have been clinically diagnosed with chronic knee osteoarthritis - People between the ages of 40 and 90 years old - People who are about to start physical therapy for knee osteoarthritis (with a first appointment coming up within the next month, or who had their first p...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06490770 · Istituto Ortopedico Rizzoli Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2027
🇮🇹 IT

Who might be able to join this trial: - You have knee pain and/or have trouble with normal knee movement or function - Your knee arthritis has been assessed as mild or early-stage (graded 2 or lower on a standard medical scale called Kellgren-Lawrence) - A camera examination inside your knee (called arthroscopy) has sh...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06493903 · Boston University Charles River Campus Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2026
🇺🇸 US

**Who might be able to join this trial:** - People aged 50 or older - People with a body mass index (a measure of weight relative to height) of 40 or below - People who self-identify as Black, including African American - People who have had knee pain rated at least 4 out of 10 on average over the past week - People wh...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06497140 · Assistance Publique - Hôpitaux de Paris Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 January 2028
🇫🇷 FR

Who might be able to join this trial: - People who have been diagnosed with primary knee osteoarthritis according to standard medical guidelines set by the American College of Rheumatology - People whose knee X-rays show osteoarthritis rated at a score of 2 or higher on a standard scale (called the Kellgren and Lawrenc...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06499038 · Helse Møre og Romsdal HF Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2027
🇳🇴 NO

Who might be able to join this trial: - People aged between 65 and 80 years old at the time of surgery who have been diagnosed with primary hip osteoarthritis (hip joint wear and tear) - People who need a first-time total hip replacement surgery - People who are willing and able to attend scheduled follow-up appointmen...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06506201 · Istituto Ortopedico Rizzoli Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 12 May 2027
🇮🇹 IT

**Who might be able to join this trial:** - People aged between 50 and 80 years - People experiencing hip osteoarthritis symptoms, including pain rated at least 6 out of 10 on a pain scale over the previous week - People with X-ray results showing moderate to severe hip osteoarthritis (classified as Grade 3 or 4 using...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06506656 · University of Roma La Sapienza Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2025
🇮🇹 IT

Who might be able to join this trial: - People aged 40 years or older - People of any gender - People who have been diagnosed with stage II or III hip joint arthritis (coxarthrosis) or thumb base joint arthritis (rhizoarthrosis), confirmed by X-ray using standard medical classification systems - People experiencing pai...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06511557 · Riphah International University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2024
🇵🇰 PK

**Who might be able to join this trial:** - Both men and women are welcome to participate. - You must be 50 years of age or older. - Your body weight relative to your height (BMI) must fall between 18.9 and 29.9 (generally considered a normal to slightly overweight range). - You must have been diagnosed with Grade II k...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06512727 · University of Florida Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2027
🇺🇸 US

**Who might be able to join this trial:** - People who identify as part of the Black American diaspora, including Black/African American or Afro-Caribbean communities - People between the ages of 50 and 92 years old - People who have had ongoing or recurring pain in their bones, joints, muscles, or related soft tissue...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06514365 · Germans Trias i Pujol Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2024
🇪🇸 ES

Who might be able to join this trial: - You have been diagnosed with osteoarthritis and are scheduled to have a total knee replacement surgery with the specific surgeons involved in this study - You will be having regional anesthesia (numbing a specific area of the body) rather than being fully put to sleep during surg...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06514703 · Zagazig University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 April 2025
🇪🇬 EG

Who might be able to join this trial: - Adults between the ages of 45 and 80 years old - People who have been diagnosed with knee osteoarthritis - People whose knee osteoarthritis has not improved with standard, non-surgical treatments - People who are able to give their informed agreement to take part in the study - P...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06514716 · Zagazig University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 April 2025
🇪🇬 EG

Who might be able to join this trial: - Adults aged 18 years or older - People who have been diagnosed with knee osteoarthritis based on physical examination and imaging results (such as X-rays) - People whose treating doctor has determined them to be suitable for a procedure called geniculate artery embolization (a pr...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06527664 · Istituto Ortopedico Rizzoli Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 March 2026
🇮🇹 IT

Who might be able to join this trial: - People who need a custom-made hip socket implant, as determined by CT scan and X-ray assessment - People who have had a pre-operative CT scan completed before surgery - Adults aged 18 years or older - People whose medical records are complete and fully available - People who are...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06532851 · Jordan University of Science and Technology Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2030
🇯🇴 JO

**Who might be able to join this trial:** - People between 35 and 55 years of age - People who have a degenerative tear in the inner cartilage pad (meniscus) of the knee, shown by pain on the inner side of the knee, tenderness along the inner knee joint, pain and limited movement when trying to do a full squat, and spe...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06549686 · CellSeed Inc. Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 31 December 2028
🇯🇵 JP

Who might be able to join this trial: - People aged 20 to 79 years old at the time of signing consent forms - People who have been diagnosed with knee osteoarthritis rated at a specific severity level (Kellgren-Lawrence Grade 2 to 4) based on a knee X-ray - People whose knee condition is suitable for a type of bone sur...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06557018 · Dezhou Hospital Qilu Hospital of Shandong University Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 31 August 2024
🇨🇳 CN

**Who might be able to join this trial:** - You are 18 years of age or older - You have been rated as generally healthy or having only mild health conditions by your anesthesia team (called ASA grade I or II), can read and understand Chinese, and are able to communicate clearly with your doctors - You are planning to h...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06563258 · Cairo University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 March 2025
🇪🇬 EG

**Who might be able to join this trial:** - You are between 40 and 60 years old - An X-ray has shown you have moderate knee osteoarthritis (specifically graded as "grade 2") - You have tenderness or soreness on the inner side of your knee (the area just below the knee joint) - Your pain level is 5 or higher on a scale...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06567301 · Cairo University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 May 2025
🇪🇬 EG

**Who might be able to join this trial:** - You are between 40 and 65 years old - You are any gender - You have been diagnosed with knee osteoarthritis (a type of joint wear-and-tear) with a moderate severity rating (Kellgren-Lawrence score of 2 or 3) confirmed by an X-ray or scan - If both knees are affected, the mor...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06574191 · University of California, Davis Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 27 January 2028
🇺🇸 US

**Who might be able to join this trial:** - People who speak English - People aged 50 years or older - People who have been diagnosed with knee osteoarthritis confirmed by X-ray at a grade 2 or higher, within the past 2 years - People who experience knee pain on at least 15 days per month - People whose worst daily pai...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06576557 · University of Limerick Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2024
🇮🇪 IE

**Who might be able to join this trial:** - You visited your GP about knee pain that was not caused by a recent injury - Your GP assessed your knee pain as being related to soft tissue issues or early wear-and-tear changes in the knee joint - You are between 35 and 69 years old (inclusive) **Who may not be able to joi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06576583 · University Hospital, Basel, Switzerland Phase 2 · 8 countries Recruiting
Recruiting Phase 2 Est. completion 1 January 2029
🇦🇹 AT🇭🇷 HR🇩🇪 DE🇮🇹 IT🇳🇱 NL🇵🇱 PL🇸🇪 SE🇨🇭 CH

**Who might be able to join this trial:** - Adults aged 18 to 70 years old at the time of screening. - People diagnosed with symptomatic patellofemoral osteoarthritis (a type of knee joint problem involving the kneecap area) graded 1–4 on the Iwano Classification scale (confirm with trial site). - People with moderate...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06578182 · Sint Maartenskliniek Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 31 March 2029
🇳🇱 NL

**Who might be able to join this trial:** - People who have been clinically diagnosed with osteoarthritis (OA) of the knee or hip - People aged between 45 and 80 years old - People who have X-ray findings showing moderate to advanced knee or hip OA (based on a standard scoring system called Kellgren & Lawrence, score o...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06592248 · Assistance Publique - Hôpitaux de Paris Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 19 December 2025
🇫🇷 FR

**Who might be able to join this trial:** - Adults under 70 years of age who were previously physically active and have knee osteoarthritis that significantly limits daily life - People whose knee osteoarthritis has not responded to standard treatments such as anti-inflammatory medications, injections, or pain relief m...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06596824 · Charite University, Berlin, Germany Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2027
🇩🇪 DE

**Who might be able to join this trial:** - People who are able to give signed written consent to participate - Adults aged between 18 and 50 years old at the time of screening - People who have had surgery to reconstruct a torn ACL (anterior cruciate ligament) in one knee, within 6 months of the injury occurring - Peo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06600958 · Assistance Publique - Hôpitaux de Paris Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 3 November 2042
🇫🇷 FR

**Who might be able to join this trial:** - People aged 18 or older, of any gender - People who have painful knee osteoarthritis in one or both knees, confirmed by an X-ray taken within the last year, showing a certain level of joint damage (confirm with trial site for exact scoring details) — or knee arthritis linked...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06603103 · Clinique du Sport, Bordeaux Mérignac Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 March 2028
🇫🇷 FR

Who might be able to join this trial: - People who have been recommended to have a first-time total knee replacement surgery. - People who are covered by a social security (health insurance) scheme. - People who have been fully informed about the study and have signed a consent form before any study-related examination...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06603831 · Corporacion Parc Tauli Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇪🇸 ES

Who might be able to join this trial: - People who need one of the following specific surgeries: a bone-reshaping procedure on the wrist (radius), a complex hip replacement surgery, or a spinal fusion surgery in the mid-to-lower back area. - People who are able to read, understand, and sign a consent form agreeing to t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06608134 · R3 Medical Research Early Phase 1 · 1 country Recruiting
Recruiting Early Phase 1 Est. completion 1 October 2028
🇺🇸 US

**Who might be able to join this trial:** - People who are over 30 years of age - People who have been diagnosed with moderate knee osteoarthritis (Grade II or III on a standard medical scale called the KL scale) in one knee - People with a Body Mass Index (BMI) below 50 kg/m² - People who rate their knee pain as 4 or...

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.
NCT06608992 · Peking University Third Hospital Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 August 2025
🇨🇳 CN

**Who might be able to join this trial:** - You have been diagnosed with knee osteoarthritis confirmed by symptoms, a physical examination, and X-rays showing a moderate-to-severe level of joint damage (stage III or higher on a standard medical scale) - You have severe knee pain that limits your daily activities, have...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06611007 · University Hospital, Grenoble Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 15 July 2028
🇫🇷 FR

**Who might be able to join this trial:** - People aged 40 years or older. - People diagnosed with hand osteoarthritis according to a specific set of medical guidelines (the 1990 American College of Rheumatology criteria). - People whose osteoarthritis affects at least two finger joints (the middle or end knuckle joint...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06611618 · Istituto Ortopedico Rizzoli Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2026
🇮🇹 IT

**Who might be able to join this trial:** - You are between 65 and 80 years old - You have been assessed with a Kellgren score of II or III, which is a measure of joint wear commonly used in knee arthritis (confirm with trial site) - You have not had any falls in the past 12 months **Who may not be able to join:** - Y...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06616896 · National Taiwan University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 12 December 2026
🇹🇼 TW

Who might be able to join this trial: - People aged between 50 and 80 years old - People who have been diagnosed with knee osteoarthritis (a condition where the knee joint wears down over time), confirmed by X-ray showing mild to moderate changes, according to standard medical guidelines Who may not be able to join: -...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06617975 · CEN Biotech Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 December 2026
🇫🇷 FR

**Who might be able to join this trial:** - People diagnosed with knee osteoarthritis rated at a certain level of severity (stage 2 to 4 on a standard medical scale), confirmed by a knee X-ray taken within the past 3 years. - People whose knee osteoarthritis causes significant difficulty with physical activities, as m...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06627673 · Maxx Orthopedics Inc Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2029
🇺🇸 US

**Who might be able to join this trial:** - People aged 18 or older, of any gender - People whose main diagnosis is advanced, severely symptomatic knee osteoarthritis in one knee only, where the joint has reached end-stage deterioration - People whose knee function score (measured using a standard tool called the Knee...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06634654 · Fondazione Policlinico Universitario Campus Bio-Medico Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇮🇹 IT

Who might be able to join this trial: - People who have knee osteoarthritis that is causing symptoms and has reached an advanced (end-stage) level - People whose knee ligaments are still working properly - People who are older than 18 years of age Who may not be able to join: - People who have a neurological condition...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06637709 · IRCCS San Raffaele Roma Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2025
🇮🇹 IT

Who might be able to join this trial: - People who have primary osteoarthritis that causes significant, disabling pain - People who are older than 18 years at the time of surgery - People who are able to communicate with healthcare professionals and give informed consent to participate - People who are willing to atten...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06640764 · Medacta International SA Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2034
🇫🇷 FR

**Who might be able to join this trial:** - You have severe hip pain or difficulty moving due to osteoarthritis, injury-related arthritis, a hip development condition, or loss of blood supply to the hip bone, and your doctor has recommended a total hip replacement. - You will be receiving a specific type of hip implant...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06643845 · University Hospital, Brest Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2031
🇫🇷 FR

**Who might be able to join this trial:** - People aged between 18 and 90 years old - People who have been diagnosed with knee osteoarthritis (wear and tear of the knee joint) rated at a moderate or higher level of severity on a standard medical scale (Kellgren stage 2 or above), without joint instability when the kne...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06651762 · Ain Shams University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 13 April 2025
🇪🇬 EG

Who might be able to join this trial: - People who are scheduled to have a total knee replacement surgery on one knee Who may not be able to join: - People who have an allergy to any of the drugs used in this study - People who have a history of alcohol or drug abuse - People who have a psychiatric illness Important:...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06653985 · ArthroBiologix Inc. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 October 2026
🇨🇦 CA

**Who might be able to join this trial:** - You are between 40 and 60 years old - You have been diagnosed with mild hip arthritis (early stage), and you may also have a torn hip labrum, a hip bone shape problem (femoroacetabular impingement), or mild hip socket shallowness (mild dysplasia) - After receiving a guided an...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06654349 · Reinier Haga Orthopedisch Centrum Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2030
🇳🇱 NL

Who might be able to join this trial: - People who have tried non-surgical treatments for osteoarthritis (a joint condition causing pain and stiffness) without enough improvement - People who are scheduled to have one of two specific hand surgeries: removal of a small wrist bone called the trapezium, or a joint replace...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06658249 · Riphah International University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 7 January 2025
🇵🇰 PK

**Who might be able to join this trial:** - People between 40 and 65 years of age (both men and women) - People who have been diagnosed with mild to moderate knee osteoarthritis (graded 1 or 2 on a standard scale) - People who have noticeable knee osteoarthritis symptoms in one or both knees, with findings confirmed by...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06658327 · Riphah International University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 November 2024
🇵🇰 PK

Who might be able to join this trial: - People between 50 and 65 years of age - People who have been diagnosed with Grade 3 osteoarthritis (a moderate-to-severe stage of joint wear and damage) - People who have given birth to 5 or more children - People who are still able to have children (fertile females) - People who...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06676189 · University Hospital, Clermont-Ferrand Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2027
🇫🇷 FR

**Who might be able to join this trial:** - People aged 18 to 90 years old who are due to have their first knee replacement surgery for knee arthritis - People who are mentally able to understand the study and agree to take part - People who are enrolled in the French social security system **Who may not be able to jo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06681142 · University of Alberta Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2026
🇨🇦 CA

Who might be able to join this trial: - People who have been regularly experiencing pain, aching, or stiffness in or around the knee for at least 1 month - People who complete the screening questionnaire called the PhIT-OA questionnaire Who may not be able to join: - People who have already had a total knee replacemen...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06684587 · Boston University Charles River Campus Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2027
🇺🇸 US

**Who might be able to join this trial:** - People aged 50 years or older who have knee pain related to activity, and either no morning knee stiffness or morning knee stiffness that lasts 30 minutes or less - People with a BMI under 40 - People who have had knee pain on most days for 3 months or longer - People whose a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06685120 · Istituto Ortopedico Rizzoli Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2029
🇮🇹 IT

**Who might be able to join this trial:** - People aged between 40 and 75 years old - People who have knee osteoarthritis with pain symptoms rated between 3 and 8 on a standard pain scale - People where only one knee is affected by symptoms - People whose knee cartilage damage has been confirmed by X-ray or MRI scan,...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06686680 · Spaulding Rehabilitation Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2026
🇺🇸 US

**Who might be able to join this trial:** - People who have had a previous ACL (knee ligament) reconstruction surgery using tissue from their own body or a donor, and who now have a form of arthritis in that knee as a result - People who had their ACL reconstruction surgery at least one year ago - People between the a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06690710 · Scarcell Therapeutics S.A.S. Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 1 February 2027
🇬🇧 GB

**Who might be able to join this trial:** - People who are willing and able to give their informed consent to take part - Men or women aged 40 years or older - People who have osteoarthritis (a type of joint wear and tear) in the inner part of the knee joint, confirmed by both knee pain and X-ray findings showing a sp...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06701474 · Yonsei University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 23 September 2025
🇰🇷 KR

**Who might be able to join this trial:** - You are 55 years of age or older (based on your national ID at the time of signing up for the trial) - You have been diagnosed with knee osteoarthritis (wear and tear of the knee joint) confirmed through your medical history, a physical exam, and X-rays or similar imaging - Y...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06704893 · Chang Gung Memorial Hospital Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 31 December 2027
🇹🇼 TW

**Who might be able to join this trial:** - People aged between 18 and 80 years old - People with a body mass index (BMI) below 40 (a measure of body weight relative to height) - People who have knee osteoarthritis with symptoms and X-ray results showing a moderate level of joint damage (rated as grade 2 or 3 on a stan...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06716281 · Shanghai IxCell Biotechnology Co., LTD Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 31 December 2025
🇨🇳 CN

**Who might be able to join this trial:** - People who have been diagnosed with knee osteoarthritis according to specific Chinese Medical Association guidelines. - People who have had ongoing knee pain for more than six months, or whose knee osteoarthritis has come back or gotten worse after stopping common treatments...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06729983 · Nickolas Garbis Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2028
🇺🇸 US

Who might be able to join this trial: - People who are at least 18 years old and are having a specific type of shoulder replacement surgery for the first time (called a "reverse total shoulder arthroplasty") - The surgery must be taking place at one of three specific locations: Loyola University Medical Center (Maywood...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06747494 · University of Miami Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2030
🇺🇸 US

Who might be able to join this trial: - People who are having their first total hip or knee replacement surgery - People who are able to understand and agree to participate in the study (give informed consent) - People who speak English or Spanish Who may not be able to join: - People who have had previous lower back...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06748651 · Dr. Amit Druyan Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 7 February 2026
🇮🇱 IL

Who might be able to join this trial: - People who have been diagnosed with osteoarthritis of the jaw joint (the temporomandibular joint, or TMJ) on the side being treated. - People whose jaw joint MRI scan shows signs of inflammation. - People whose blood test results (checking general health, salt levels, and kidney...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06753019 · Suleyman Demirel University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2024
Turkey (Türkiye)

**Who might be able to join this trial:** - People who have been diagnosed with knee osteoarthritis and have had knee complaints for at least 6 months **Who may not be able to join:** - People who have a rheumatological (joint or immune-related) disease other than osteoarthritis - People whose knee pain is caused by a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06755697 · Shin Kong Wu Ho-Su Memorial Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇹🇼 TW

**Who might be able to join this trial:** - People aged between 45 and 80 years old - People who meet at least three of the following six features of knee osteoarthritis (as assessed by a doctor): being over 50 years old, morning stiffness that lasts less than 30 minutes, a crackling or grinding sensation when the knee...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06762171 · Sohag University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2025
🇪🇬 EG

Who might be able to join this trial: - People aged between 35 and 60 years old - People with mild to moderate knee joint arthritis (tibiofemoral osteoarthritis), graded I, II, or III on the Kellgren-Lawrence scale - People who have pain at the front of the knee (patellofemoral osteoarthritis) - People where the inner...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06781463 · University of Chicago Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2028
🇺🇸 US

**Who might be able to join this trial:** - You are 18 years of age or older - You have knee pain in one or both knees that has been diagnosed as knee osteoarthritis (if both knees are affected, only the more severely affected knee would be included) - Your knee osteoarthritis has been confirmed by a standing X-ray and...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06782347 · Milton S. Hershey Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2028
🇺🇸 US

Who might be able to join this trial: - People who are aged 65 or older. - People who have been diagnosed with hip, knee, or general osteoarthritis, recorded using a standard medical diagnosis code. - People who have confirmed through a standardised survey question that a doctor told them they have osteoarthritis or ar...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06782529 · Mayo Clinic Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 24 January 2027
🇺🇸 US

Who might be able to join this trial: - People with a BMI of 30 or higher who have knee osteoarthritis confirmed by an X-ray, and who are interested in receiving a steroid injection for their knee arthritis. Who may not be able to join: - People with a BMI below 30. - People with diabetes that is not well controlled,...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06793982 · LifeBridge Health Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 December 2025
🇺🇸 US

**Who might be able to join this trial:** - You are willing to sign and date a consent form agreeing to take part in the study - You are willing to follow all study procedures and are available for the full length of the study - You are male or female, between 21 and 80 years old - You have been diagnosed with hip oste...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06794632 · Parker Research Institute Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2025
🇩🇰 DK

Who might be able to join this trial: - People who have been diagnosed with hand osteoarthritis by their general practitioner - People aged 18 years or older - People who are experiencing reduced ability to carry out everyday activities (such as dressing, cooking, or personal care) Who may not be able to join: - Peopl...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06805188 · Wu zenan Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 5 January 2026
🇨🇳 CN

**Who might be able to join this trial:** - People aged 18 to 70 years old, of any gender - People who have been diagnosed with knee osteoarthritis according to the American College of Rheumatology (ACR) diagnostic standards - People whose knee pain scores at least 4 out of 10 on a standard pain scale, and whose pain h...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06807541 · University of the Fraser Valley Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 19 June 2025
🇨🇦 CA

Who might be able to join this trial: - People who have been diagnosed with osteoarthritis in the inner side of the knee by a doctor, or who meet a set of established medical guidelines for this type of knee osteoarthritis - People who pass a safety questionnaire (called the Get Active Questionnaire) confirming that st...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06809998 · Unity Health Toronto Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 30 July 2026
🇨🇦 CA

**Who might be able to join this trial:** - You are 18 years of age or older - You have been diagnosed with osteoarthritis and are scheduled to have a knee replacement on one knee (not both at the same time) - Your other knee (the one not being replaced) has not had steroid or biologic injections in the past year - You...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06823089 · Cytex Therapeutics, Inc. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2031
🇺🇸 US

**Who might be able to join this trial:** - People aged 14 to 64 years old (those aged 14 to 21 must have imaging showing their hip bones have finished growing) - People with a body mass index (BMI) under 35 - People who have already tried at least 6 weeks of non-surgical treatment, such as pain or anti-inflammatory m...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06825650 · Hacettepe University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 28 November 2027
Turkey (Türkiye)

Who might be able to join this trial: - People who have been diagnosed with a musculoskeletal pain condition, specifically osteoarthritis, back pain, or fibromyalgia - People who are 18 years of age or older - People who are willing and able to give their informed consent to participate Who may not be able to join: -...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06829433 · University of Portsmouth Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2026
🇬🇧 GB

**Who might be able to join this trial:** - You have been diagnosed with knee osteoarthritis (worn knee joint) in one or both knees that causes symptoms such as pain or stiffness - You feel you are able to walk for 10 minutes without using a walking aid (such as a cane or walker) - You are able to go up and down stairs...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06833749 · KeyBioscience AG Phase 2 · 6 countries Recruiting
Recruiting Phase 2 Est. completion 1 November 2026
🇨🇿 CZ🇩🇰 DK Hong Kong Moldova🇵🇱 PL🇷🇴 RO

**Who might be able to join this trial:** - People who are able to read, understand, and sign a consent form agreeing to take part in the study - People who are willing and able to follow the study's instructions and attend all required visits - People who have been diagnosed with osteoarthritis (OA) of the knee, with...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06843980 · Moximed Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 April 2026
🇺🇸 US

**Who might be able to join this trial:** - People who have knee pain that gets worse with activity, located specifically on the inner side of the knee (not the whole knee) - People whose knee pain scores at least 40 out of 100 on a standard pain measurement scale called the WOMAC - People who have already tried non-su...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06845553 · Glaceum Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 31 July 2026
🇰🇷 KR

**Who might be able to join this trial:** - People who have given their written consent to take part after being fully informed about the trial. - Adults between 40 and 75 years of age at the time of screening. - People diagnosed with knee osteoarthritis according to recognised medical criteria, with symptoms lasting...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06845657 · Riphah International University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 16 February 2026
🇵🇰 PK

**Who might be able to join this trial:** - You are between 40 and 60 years old - You are any gender (male or female) - You have been experiencing knee pain for 3 months or longer - Your average knee pain has been at least 4 out of 10 in the past week - Your X-ray shows a moderate level of knee joint damage (graded as...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06850818 · University Hospital Heidelberg Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2035
🇩🇪 DE

Who might be able to join this trial: - People who are having a hip or knee replacement surgery at the participating hospital - People who are having follow-up (revision) surgery after a previous hip or knee replacement Who may not be able to join: - People who have not given their consent in advance to take part in t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06856356 · The First Affiliated Hospital of University of Science and Technology... Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2025
🇨🇳 CN

**Who might be able to join this trial:** - People aged 18 to 80 years old (inclusive), of any gender, who agree to take part and sign a consent form - People who need total knee replacement surgery - People who are able to communicate clearly with the research team and are willing to follow the trial requirements **W...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06859164 · University of Chicago Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 31 August 2026
🇺🇸 US

**Who might be able to join this trial:** - You are between 40 and 80 years old - You have knee pain in one or both knees that has been diagnosed as osteoarthritis - Your knee X-rays (taken while standing) show a moderate to severe level of osteoarthritis (Grade 2–4 on a standard medical scale) - You have had knee pain...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06863636 · Laboratorios Silanes S.A. de C.V. Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 30 October 2025
🇲🇽 MX

**Who might be able to join this trial:** - People who are willing to take part and sign a written consent form agreeing to participate. - People who have previously been diagnosed with osteoarthritis of the knee or hip, based on recognised medical criteria. - People currently experiencing a flare-up of pain in the af...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06872567 · North American Science Associates Ltd. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇺🇸 US

Who might be able to join this trial: - The person has pain in one or both knees that is located in a specific area. - The person is considered a suitable candidate for a procedure involving access to an artery (a blood vessel that carries blood from the heart). Who may not be able to join: - The person has a known se...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06875817 · Riphah International University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 2 September 2025
🇵🇰 PK

**Who might be able to join this trial:** - People between 40 and 60 years of age - Both men and women are eligible - People who are able to walk for 6 minutes and complete a basic standing and walking test (called the Timed Up-and-Go test) - People who are able to get up from the floor - People who have been diagnosed...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06878417 · University Health Network, Toronto Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇨🇦 CA

Who might be able to join this trial: - People between 40 and 80 years of age - People who have been diagnosed with hip and/or knee osteoarthritis according to specific rheumatology guidelines set by the American College of Rheumatology - People experiencing a moderate to severe level of pain that interferes with daily...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06887829 · Mayo Clinic Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 28 June 2026
🇺🇸 US

**Who might be able to join this trial:** - People whose primary care provider is based at Mayo Clinic in Rochester, MN - People aged between 50 and 100 years old - People who experience at least moderate knee pain, as measured by a specific pain questionnaire called the ICOAP scale - People who have been diagnosed wit...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06891807 · Medisch Centrum Latem Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2027
🇧🇪 BE

Who might be able to join this trial: - You are between 18 and 85 years old - You are scheduled to have a total knee replacement surgery for the first time - You are willing to sign a consent form agreeing to take part in the study - Your knee surgery is needed because of osteoarthritis (wear and tear of the knee joint...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06893302 · Hospital for Special Surgery, New York Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2028
🇺🇸 US

**Who might be able to join this trial:** - You need to be scheduled for a first-time knee arthroscopy (a minor surgical procedure using a small camera) to treat a meniscal (cartilage cushion) injury or a small area of cartilage damage, specifically a cleaning-out or trimming procedure - Your knee shows no signs of art...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06899932 · Hospital de Sant Rafael Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2032
🇪🇸 ES

Who might be able to join this trial: - Adults over 18 years old who have knee osteoarthritis that has not improved with non-surgical treatments - People who are able to understand and agree to take part in the study by signing a consent form - People who are receiving a specific type of total knee replacement implant...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06906939 · University of California, Los Angeles Early Phase 1 · 1 country Recruiting
Recruiting Early Phase 1 Est. completion 30 June 2029
🇺🇸 US

Who might be able to join this trial: - People aged 50 years or older. - People who have experienced pain in one or more areas of the body for 6 months or more. - People whose knee pain meets the recognised criteria for osteoarthritis, including having visible bone changes on an X-ray and/or knee pain on most days over...

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.
NCT06911359 · David Grant U.S. Air Force Medical Center Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 31 December 2026
🇺🇸 US

Who might be able to join this trial: - People who receive their healthcare through the Department of Defense (DoD) and are registered as patients at David Grant Medical Center (DGMC) - Adults between 45 and 75 years old who have been diagnosed with knee osteoarthritis (joint wear and tear) in one or both knees, based...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06914960 · Bengu Turemenogullari Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 August 2026
Turkey (Türkiye)

Who might be able to join this trial: - People who are between 30 and 75 years old - People who have had ongoing knee pain for at least 6 months - People whose X-rays show moderate to severe osteoarthritis (Grade 3 or 4 on a standard medical scale) with significant narrowing of the space inside the knee joint - People...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06915363 · BioPoly LLC Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2028
🇺🇸 US

**Who might be able to join this trial:** - You are between 30 and 65 years old. - Your knee quality-of-life score (measured by a questionnaire called KOOS) is 60 or below, meaning your knee significantly affects your daily life. - You are willing and able to follow all study requirements, including post-surgery rehab...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06916676 · Al Hayah University In Cairo Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2027
🇪🇬 EG

Who might be able to join this trial: - People who are between 45 and 75 years old (inclusive) - People who have been diagnosed with knee osteoarthritis based on standard medical criteria, which includes knee pain along with at least 3 of the following: being over 50 years old, morning stiffness lasting less than 30 mi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06920459 · Zimmer Biomet Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 1 June 2029
🇩🇪 DE🇳🇱 NL

**Who might be able to join this trial:** - You are 20 years of age or older. - Your shoulder anatomy is suitable to receive a shoulder replacement implant, as determined by your doctor. - You need a shoulder replacement due to one of the following: osteoarthritis, bone tissue death due to loss of blood supply (avascul...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06929871 · University College, London Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 July 2031
🇬🇧 GB

**Who might be able to join this trial:** - People who have painful knee osteoarthritis and need a first-time total knee replacement surgery - People whose surgeon agrees that a total knee replacement is the most suitable treatment for their condition - People who have been assessed by a surgeon and anaesthetist and ar...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06932614 · Tri-Service General Hospital (TSGH) Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 July 2026
🇹🇼 TW

**Who might be able to join this trial:** - People aged between 21 and 79 years old (over 20 and under 80). - People who are alert, aware, and able to communicate clearly. - People who have knee osteoarthritis in one or both knees, with symptoms that have been present for more than 3 months. - People whose knee X-rays...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06934421 · Centro Hospitalar Universitario do Algarve Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 14 July 2028
🇵🇹 PT

**Who might be able to join this trial:** - People who have long-term knee pain caused by moderate-to-severe knee osteoarthritis, confirmed by X-ray (specifically rated as Grade 3 or 4 on a standard medical scale called Kellgren-Lawrence) - People whose knee pain and limited movement have not improved enough after com...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06960564 · Istanbul University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 January 2026
Turkey (Türkiye)

**Who might be able to join this trial:** - You have been diagnosed with knee osteoarthritis (knee joint wear and tear) based on standard medical guidelines - You have had knee pain for more than 3 months - Your knee pain has not improved with standard treatments (such as physiotherapy or pain medication) for at least...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06965452 · Northwell Health Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2026
🇺🇸 US

**Who might be able to join this trial:** - You are between 18 and 85 years old - A scan (MRI or CT) has confirmed you have arthritis in the small joints of your spine (called facet joints) - Special nerve block injections have confirmed that these spinal joints are the source of your back pain - Your back pain has la...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06968143 · University of Chicago Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 April 2027
🇺🇸 US

Who might be able to join this trial: - People who are 18 years of age or older - People who are having a total knee replacement surgery (either for the first time or as a repeat/revision procedure) using either a smart knee implant or a standard knee implant Who may not be able to join: - People who have a knee repla...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06986694 · Riphah International University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2025
🇵🇰 PK

**Who might be able to join this trial:** - People aged between 45 and 65 years old - Both men and women are eligible - People who have had knee pain lasting at least 3 months - People whose knee pain during walking rates at least 2 out of 10 on a pain scale - People who have difficulty with walking and balance, as mea...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06994546 · Maxigen Biotech Inc. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 November 2025
🇹🇼 TW

**Who might be able to join this trial:** - People aged between 35 and 85 years old. - People who have had an X-ray within the last month showing knee osteoarthritis rated as a specific level of severity (Kellgren Lawrence grade 2 or 3) (confirm with trial site). - People diagnosed with mild to moderate knee osteoarthr...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07001761 · Sohag University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 25 April 2026
🇪🇬 EG

Who might be able to join this trial: - People who are older than 30 years of age - People who have one or both knees affected by the condition being studied - People who are currently experiencing symptoms related to their knee joint(s) Who may not be able to join: - Women of childbearing age who have a chronic infla...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07003113 · University of Illinois at Chicago Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 July 2026
🇺🇸 US

Who might be able to join this trial: - People who have knee pain that meets a standard medical checklist called the ACR Criteria - People who have back pain that scores above 12 on a standard questionnaire called the ODI - People who are able to walk for at least 3 minutes without using any walking aids - People who a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07006883 · University of Nove de Julho Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 January 2029
🇧🇷 BR

**Who might be able to join this trial:** - People who have been clinically diagnosed with knee osteoarthritis, meaning they have had knee pain for more than 3 months - People whose morning joint stiffness lasts less than 30 minutes - People whose knees make a cracking or grinding sound when moving (crepitus) - People...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07016672 · Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇫🇷 FR

**Who might be able to join this trial:** - People who are 18 years of age or older - People who have been confirmed by MRI scan to have moderate to severe knee joint wear (grade III or IV) in one knee only - People whose knee pain is rated at least 3 out of 10 on a standard pain scale - People with a body mass index (...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07023185 · Ochsner Health System Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2027
🇺🇸 US

Who might be able to join this trial: - People aged 50 years or older - People who are a patient of Dr. Howard Hirsch or Dr. Vinod Dasa and are scheduled for a total knee replacement surgery at Ochsner Kenner - People who plan to receive all of their post-surgery physical therapy as an outpatient at OTW Driftwood - Peo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07036003 · Dr. David Wasserstein Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 July 2028
🇨🇦 CA

**Who might be able to join this trial:** - People who are between 18 and 65 years old - People who have been diagnosed with osteoarthritis affecting only one or both knees for more than 6 months **Who may not be able to join:** - People who have had major surgery on the affected knee, such as bone realignment, ligame...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07040878 · Wroclaw University of Health and Sport Sciences Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇵🇱 PL

**Who might be able to join this trial:** - You are 60 years old or older and have recently had a hip or knee joint replacement surgery **Who may not be able to join:** - You have a memory or thinking problem that would stop you from filling out questionnaires on your own - You have a history of losing consciousness,...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07055113 · University of Alberta Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2028
🇨🇦 CA

Who might be able to join this trial: - People who have been diagnosed with hip or knee osteoarthritis, but whose doctors have determined they do not currently need joint replacement surgery (and are not on a surgical waiting list) - People who are not currently receiving physiotherapy treatment - People who live outsi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07058623 · Hospital Authority, Hong Kong Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 28 February 2026
Hong Kong

Who might be able to join this trial: - Adults aged 18 years or older - People having their first-ever total knee replacement surgery - People who are within 4 weeks after their knee replacement surgery - People who are medically stable enough to leave hospital and be cared for at home - People who have access to a sma...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07069179 · University of British Columbia Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2028
🇨🇦 CA

Who might be able to join this trial: - You are an activity coach hired by the Active Aging Society and you speak English - You are an older adult aged 50 or over who speaks English and takes part in the CTM-RR program - You work in a healthcare setting and refer patients into this program (known as a referral partner)...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07079254 · Region Skane Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2035
🇸🇪 SE

Who might be able to join this trial: - People aged 15 years or older. - People who have a specific type of knee cartilage tear (called a displaced longitudinal bucket-handle tear involving the posterior horn) confirmed by an MRI scan, along with difficulty fully straightening the knee. Who may not be able to join: -...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07080814 · Ankara Etlik City Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2027
Turkey (Türkiye)

Who might be able to join this trial: - People who have had a total knee replacement surgery within the past 2 years and are currently admitted to the Orthopedic Rehabilitation Clinic at Ankara Etlik City Hospital, Physical Therapy Hospital. - People who are able to put their full body weight on the leg that was operat...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07089251 · King Abdullah International Medical Research Center Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 24 June 2027
🇸🇦 SA

Who might be able to join this trial: - People who are having knee joint replacement surgery. - People of any nationality, whether Saudi or non-Saudi. - People who have a complete medical record available. Who may not be able to join: - People who have end-stage kidney failure. - People who have severe scarring of the...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT07094100 · The First Affiliated Hospital of Xinxiang Medical College Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇨🇳 CN

**Who might be able to join this trial:** - People aged between 18 and 65 years old (any gender) - Bone growth is fully mature, as shown on imaging scans - There is damage or localised injury to the cartilage in a joint, caused by trauma or another reason - The injured area is on the lower weight-bearing surface of th...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07104084 · F. Johannes Plate Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2027
🇺🇸 US

Who might be able to join this trial: - People who have been diagnosed with osteoarthritis or avascular necrosis (bone tissue death due to lack of blood supply) of the hip joint, have already tried non-surgical treatments without enough improvement, and have been recommended for a total hip replacement surgery Who may...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07104279 · Zimmer Biomet Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2028
🇺🇸 US

**Who might be able to join this trial:** - You are at least 18 years old and your bones have finished growing - Your doctor believes you are physically and mentally able to follow the study's requirements, including attending all scheduled visits - You (or your legal representative) are willing and able to review and...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07105657 · Horsens Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇩🇰 DK

Who might be able to join this trial: - You have had a hip or knee replacement and have been admitted to hospital for intensive rehabilitation afterwards Who may not be able to join: - You are not able to understand Danish - You are not able to take part in physical tests - You are not able to understand and fill in q...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07118501 · Stryker Trauma and Extremities Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2030
🇺🇸 US

Who might be able to join this trial: - People who are willing and able to sign an approved consent form before taking part - People who are male or non-pregnant female, aged 21 years or older at the time of surgery - People who are willing and able to attend all required study visits and follow the study plan - People...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07121556 · Istituto Ortopedico Rizzoli Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2030
🇮🇹 IT

**Who might be able to join this trial:** - Adults between 18 and 75 years of age - People who have X-ray evidence of osteoarthritis in both knees, rated between 2 and 4 on a standard medical severity scale (the Kellgren-Lawrence scale) - People who have pain of 4 or higher (out of 10) in both knees, as measured on a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07125833 · North Texas Medical Research Institute, PLLC Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2026
🇺🇸 US

**Who might be able to join this trial:** - People who are male, or female and not currently pregnant and not planning to become pregnant during the trial - People aged between 30 and 85 years old - People with a body mass index (BMI) of 45 or below - People who are already scheduled for a planned, non-emergency rever...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07134244 · Aalborg University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 26 September 2035
🇩🇰 DK

**Who might be able to join this trial:** This trial has several different groups. Depending on their situation, people may be considered for one of the following: **ACL Reconstruction Group:** - Adults aged under 70 who have injured their ACL within the past year and have a planned surgery to reconstruct it - Have s...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07140367 · Istituto Ortopedico Rizzoli Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2029
🇮🇹 IT

Who might be able to join this trial: - People who are over 40 years of age - People who have been diagnosed with moderate knee joint wear-and-tear (specifically graded 2–3 on a standard medical scale called the Kellgren-Lawrence score), and whose doctor has already recommended knee replacement surgery - People whose k...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07153471 · Eli Lilly and Company Phase 3 · 8 countries Recruiting
Recruiting Phase 3 Est. completion 1 April 2028
🇨🇦 CA🇨🇳 CN🇩🇪 DE🇮🇳 IN🇯🇵 JP🇲🇽 MX🇪🇸 ES🇺🇸 US

**Who might be able to join this trial:** - Your Body Mass Index (BMI) is 27 or higher (a measure of body weight relative to height) - You have tried at least one diet to lose weight in the past, but it did not work - You have been diagnosed with osteoarthritis of the knee, AND at least one of the following applies to...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07161336 · Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 July 2026
Bangladesh

**Who might be able to join this trial:** - Men and women between 40 and 70 years old - People diagnosed with knee osteoarthritis based on established medical criteria, including knee pain plus at least 3 out of a specific set of 4 clinical signs (confirm with trial site for full details) - People who have had knee pai...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07168590 · Selim Sezikli Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 8 September 2026
Turkey (Türkiye)

Who might be able to join this trial: - People who have been diagnosed with knee osteoarthritis, confirmed by both a physical examination and X-ray imaging. - People who have had an X-ray of the knee taken within the last 6 months. - People who are willing to take part in the study voluntarily. - People who have the me...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07178223 · Karolinska Institutet Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2038
🇸🇪 SE

**Who might be able to join this trial:** - People who have osteoarthritis at the base of the thumb, confirmed by X-ray at a certain stage of severity (stages 1–3 on a medical scale used to classify this condition) - People who have physical signs of thumb base osteoarthritis, including pain when the joint is pressed a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07180979 · Poznan University of Medical Sciences Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 30 September 2026
🇵🇱 PL

**Who might be able to join this trial:** - You are 65 years of age or older - Your general health has been assessed by a doctor and falls within a certain range of fitness for medical procedures (this is called ASA status I–III — confirm with trial site if unsure which category applies to you) - You are scheduled for...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT07190339 · Diskapi Teaching and Research Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 20 April 2026
Turkey (Türkiye)

**Who might be able to join this trial:** - You have hip and groin pain and have been diagnosed with hip osteoarthritis (wear and tear of the hip joint) confirmed by an X-ray. - You have had hip pain rated above 5 out of 10 on a pain scale for more than 6 weeks. - Your pain has not been adequately relieved by standard...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07198555 · Belief BioMed (Beijing) Co., Ltd Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 30 December 2027
🇨🇳 CN

Who might be able to join this trial: - People who have been diagnosed with moderate knee osteoarthritis. - People whose knee has been graded as Kellgren-Lawrence grade 2 or 3 (a standard scale used to measure the severity of knee osteoarthritis — confirm with trial site if unsure what grade applies). - People whose Bo...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07198750 · Hospital Civil de Guadalajara Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 5 February 2026
🇲🇽 MX

**Who might be able to join this trial:** - People aged 60 or older - People who have been diagnosed with knee osteoarthritis (a condition where the knee joint wears down over time), confirmed by a doctor's assessment and imaging, ranging from mild to severe - People who have had knee pain rated at least 3 out of 10 o...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07199751 · Technical University of Munich Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇩🇪 DE

Who might be able to join this trial: - People who are 18 years of age or older - People who are scheduled to have surgery at Klinikum rechts der Isar, Technical University of Munich (TUM) - People who have given written consent to take part in the study after receiving a full explanation of what the trial involves, in...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07217405 · Mayo Clinic Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 May 2027
🇺🇸 US

**Who might be able to join this trial:** - You are a patient at Mayo Clinic in Rochester, MN - You are 50 years old or older - You have been diagnosed with mild, moderate, or severe hand osteoarthritis, confirmed by an X-ray taken within the last 2 years - You experience hand pain of at least 40 out of 100 on a pain s...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT07224958 · Rush University Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2027
🇺🇸 US

Who might be able to join this trial: - People aged between 40 and 85 years old - People with a body mass index (a measure of body weight relative to height) of 35 or below - People who have been told by a doctor that they have osteoarthritis affecting the inner side of the knee - People who rate their knee pain while...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07226258 · Saol Therapeutics Inc Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 30 November 2026
🇺🇸 US

Who might be able to join this trial: - People who are male or female and aged 40 years or older - People whose body weight falls within a specific range based on their height (confirm with trial site for exact BMI limits) - People who have ongoing knee pain caused by osteoarthritis - People whose osteoarthritis has be...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07226973 · Ochsner Health System Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 November 2027
🇺🇸 US

Who might be able to join this trial: - Adults over 18 years old who are scheduled to have a planned (non-emergency) total hip replacement for osteoarthritis (joint wear and tear) - People with a Body Mass Index (BMI) below 35 - People who are able to walk more than 150 feet (about 45 metres) before the operation, even...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07238751 · Riphah International University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 20 September 2026
🇵🇰 PK

Who might be able to join this trial: - People between 40 and 60 years old - Both men and women are eligible - People whose hamstring muscles (the muscles at the back of the thigh) are tight, shown by specific movement tests where the hip cannot bend past 80 degrees or the knee cannot fully straighten (confirm with tri...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07248072 · Ataturk University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2026
Turkey (Türkiye)

Who might be able to join this trial: - People between 18 and 75 years of age - People who are scheduled for a planned, first-time knee replacement surgery on one knee - People whose surgery is planned to use spinal anaesthesia (numbing the lower body rather than general anaesthesia) - People whose overall health statu...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07267793 · DALIM TISSEN Co., Ltd. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2026
🇰🇷 KR

**Who might be able to join this trial:** - People aged 19 years or older - People who have been diagnosed with osteoarthritis in one or both knees, based on specific medical criteria that include at least 3 of these 6 features: being aged 50 or older, morning stiffness lasting less than 30 minutes, a crackling or gra...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07288970 · Poznan University of Medical Sciences Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2027
🇵🇱 PL

**Who might be able to join this trial:** - People aged 65 years or older - People who are scheduled for a planned (non-emergency) knee replacement surgery on one knee, under spinal or general anaesthesia - People whose overall health status falls within a range that anaesthetists classify as ASA I, II, or III (meanin...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07288983 · Poznan University of Medical Sciences Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2027
🇵🇱 PL

**Who might be able to join this trial:** - Adults aged 65 years or older who are scheduled to have a planned (non-emergency) hip replacement surgery using spinal anaesthesia - People who are able to give written consent to participate - People who are able to understand and use a simple pain rating scale from 0 to 10...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07300384 · University of Valencia Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇪🇸 ES

**Who might be able to join this trial:** - People between 50 and 85 years of age - People who have been diagnosed with severe knee joint disease (wear and tear of the knee) based on recognised medical and imaging guidelines - People who are already on a waiting list for a single knee replacement surgery **Who may not...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07301242 · Shanghai Geriatric Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2026
🇨🇳 CN

**Who might be able to join this trial:** - People who are 65 years of age or older - People with a body weight that falls within a moderate, healthy range (a BMI between 18 and 30) - People whose overall physical health before surgery is rated as good to moderately managed (ASA classification I–III — confirm with tria...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07302204 · University of Nove de Julho Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 20 December 2029
🇧🇷 BR

**Who might be able to join this trial:** - People who have been diagnosed with knee osteoarthritis that causes symptoms, for at least 3 months. - People who have had knee pain for more than 3 months, with an average pain level of 3 or higher on a scale of 0 to 10. - People whose morning knee stiffness lasts less than...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07304323 · I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 October 2026
🇮🇹 IT

**Who might be able to join this trial:** - You were admitted to the IRCCS Galeazzi Orthopedic Institute in 2018 for a total hip or knee replacement surgery, and then moved to an inpatient rehabilitation unit within the same facility after your surgery. - You are 18 years of age or older. - Your diagnosis was recorded...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07308873 · University of Pittsburgh Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2030
🇺🇸 US

**Who might be able to join this trial:** - People who have had knee pain for more than 6 months - People whose knee pain is rated more than 3 out of 10 in severity, caused by osteoarthritis, and has been present on more than half of days in the past month - People whose knee X-ray shows moderate to significant joint d...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07309003 · Ankara City Hospital Bilkent Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2025
Turkey (Türkiye)

Who might be able to join this trial: - People who are between 50 and 65 years old - People who have been diagnosed with primary knee osteoarthritis (wear-and-tear arthritis that originates in the knee itself, not caused by another condition) based on standard medical criteria - People whose knee osteoarthritis has bee...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07313449 · University Hospital, Strasbourg, France Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2026
🇫🇷 FR

**Who might be able to join this trial:** - People who are adults (18 years of age or older) - People who had a total knee replacement surgery performed between January 2013 and December 2024 - People whose knee replacement used a specific type of implant: an Anatomic, Amplitude, posteriorly stabilized, fixed polyethyl...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07316933 · University of Valencia Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇪🇸 ES

**Who might be able to join this trial:** - People aged between 50 and 85 years - People who have been diagnosed with severe knee joint deterioration (known as gonarthrosis), confirmed using recognised medical and imaging guidelines - People who are already on a waiting list for a single knee replacement surgery **Who...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07320118 · Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 12 January 2030
🇬🇧 GB

Who might be able to join this trial: - People who are receiving a treatment called ACI (Autologous Chondrocyte Implantation) or who are receiving a different/alternative treatment for their condition (confirm with trial site) Who may not be able to join: - Anyone who does not meet the inclusion criteria listed above...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07323342 · Cao Kim Xoa Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2026
🇻🇳 VN

**Who might be able to join this trial:** - People aged between 45 and 75 years old, of any gender - People who have been diagnosed with primary knee osteoarthritis using a specific set of medical guidelines called the ACR 1991 criteria - People of Vietnamese background - People who have agreed in writing to take part...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07323745 · Universiti Sains Malaysia Early Phase 1 · 1 country Recruiting
Recruiting Early Phase 1 Est. completion 31 December 2026
🇲🇾 MY

**Who might be able to join this trial:** - People who are over 50 years of age at the time of joining the trial. - People who have been diagnosed with osteoarthritis in one or both knees, based on clinical and imaging assessments carried out according to American College of Rheumatology standards. - People whose knee...

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.
NCT07324746 · Middlesex University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2026
🇬🇧 GB

**Who might be able to join this trial:** - You are 18 years of age or older - You have been diagnosed with osteoarthritis in your knee or hip - Your pain during your most painful movement in the last 24 hours rates at least 4 out of 10 on a pain scale - Your osteoarthritis significantly affects your daily functioning,...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07327892 · Poznan University of Medical Sciences Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2027
🇵🇱 PL

**Who might be able to join this trial:** - People aged 65 years or older - People who are scheduled for planned or emergency hip surgery, such as surgery to repair a hip fracture or replace a hip joint - People whose overall health status falls within a certain range as assessed by their anaesthetist or doctor (known...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07327931 · Poznan University of Medical Sciences Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2026
🇵🇱 PL

**Who might be able to join this trial:** - People aged 65 years or older - People who are scheduled for hip surgery, either planned (elective) or urgent (emergency), such as surgery to repair a hip fracture or replace a hip joint - People whose overall health before surgery falls within a low-to-moderate risk range, a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07329023 · The Hong Kong Polytechnic University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 November 2027
Hong Kong

Who might be able to join this trial: - People who are of Chinese ethnicity - People aged 60 years or older - People who are able to read Chinese and understand Mandarin or Cantonese - People who have at least 3 of the following knee symptoms: morning stiffness lasting 30 minutes or more; a clicking or cracking sound w...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07329361 · MiKS Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇪🇸 ES

Who might be able to join this trial: - People of any gender are welcome to participate. - You must be between 40 and 85 years old. - You must have been diagnosed with osteoarthritis based on a clinical examination and imaging (such as an X-ray). - Your joint pain score must be 75 points or below when measured using a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07330999 · Poznan University of Medical Sciences Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2027
🇵🇱 PL

**Who might be able to join this trial:** - People aged 65 years or older - People scheduled for hip surgery, either planned in advance or as an emergency (for example, hip fracture repair or hip replacement) - People whose overall health before surgery falls within a low-to-moderate risk range, as assessed by their a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07339111 · Medipost, Inc. Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 30 June 2029
🇺🇸 US

**Who might be able to join this trial:** - Adults aged 18 to 75 years old. - People who have been diagnosed with knee osteoarthritis in the target knee, based on established medical guidelines. - People who have tried non-surgical treatments for their knee osteoarthritis (such as weight loss, physical therapy, inject...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07347821 · Medical University of Warsaw Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇵🇱 PL

Who might be able to join this trial: - You are 18 years old or older - You are scheduled to have your first-ever knee or hip replacement surgery - You have been diagnosed with osteoarthritis (wear-and-tear joint disease) in your hip or knee - Enough tissue samples of good quality can be collected from you during the p...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07351968 · Shandong Suncadia Medicine Co., Ltd. Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 1 August 2026
🇨🇳 CN

**Who might be able to join this trial:** - People who are willing to sign a consent form before any trial activities begin - People who rate their knee pain at 4 or higher on a numbered pain scale (0–10) at their first screening appointment - People who are willing to stop all other medical and non-medical treatments...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07353931 · Eli Lilly and Company Phase 3 · 15 countries Recruiting
Recruiting Phase 3 Est. completion 1 March 2028
🇦🇷 AR🇧🇪 BE🇧🇷 BR🇨🇦 CA🇨🇳 CN🇨🇿 CZ🇩🇰 DK🇩🇪 DE +7 more

Who might be able to join this trial: - Your Body Mass Index (BMI) is 27 or higher (a measure of weight relative to height) at the time of screening - Your weight has been fairly stable — changing less than 5% — for the past 3 months before screening - You have tried at least one diet to lose weight in the past but wer...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07360093 · Ankara City Hospital Bilkent Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2027
Turkey (Türkiye)

Who might be able to join this trial: - People who have had ongoing hip pain for at least 3 months - People whose hip pain scores at least 4 out of 10 on a standard pain scale - People who have been diagnosed with hip osteoarthritis through a physical examination and/or imaging (such as an X-ray) - People whose hip pai...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07361198 · Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 23 December 2026
🇨🇿 CZ

Who might be able to join this trial: - Adults between the ages of 40 and 80 years - People experiencing ongoing knee pain symptoms - People who have imaging-confirmed knee joint degeneration at a moderate to severe level, or who continue to have knee pain after having a full knee replacement surgery - People who have...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07367789 · Yonsei University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇰🇷 KR

Who might be able to join this trial: - People aged 19 years or older - People who have been diagnosed with knee osteoarthritis (a condition where the cartilage in the knee breaks down), confirmed by a specific medical grading scale - People who have a knee replacement surgery already planned at one of the study locati...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07370480 · CEN Biotech Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 10 February 2027
🇫🇷 FR

**Who might be able to join this trial:** - People who have been diagnosed with knee osteoarthritis at a moderate to severe level (stages 2 to 4), confirmed by a knee X-ray taken within the past 3 years. - People whose knee osteoarthritis causes significant difficulty with physical activities, based on a standard ques...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07371572 · Sint Maartenskliniek Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 April 2028
🇳🇱 NL

**Who might be able to join this trial:** - People who have been diagnosed with osteoarthritis (a type of joint wear and tear) affecting the finger joints, confirmed using X-rays taken within the last 6 months and matching reported symptoms. - People aged 16 years or older. - People who have hand pain rated above 40 o...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07381621 · Ankara Training and Research Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2026
Turkey (Türkiye)

Who might be able to join this trial: - People who have knee osteoarthritis that is causing symptoms such as pain or stiffness - People whose knee osteoarthritis has been confirmed through a clinical examination, imaging, or both - People who have been experiencing knee pain for 3 months or longer - People who have giv...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07386600 · Poznan University of Medical Sciences Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2027
🇵🇱 PL

Who might be able to join this trial: - People who are 65 years of age or older - People who are scheduled to have a single knee replacement surgery (on one knee only) for the first time, under a standard anaesthetic plan - People whose overall health has been assessed by a doctor as falling within a moderate range of...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07396233 · University of Karachi Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 19 January 2027
🇵🇰 PK

**Who might be able to join this trial:** - People between 40 and 60 years of age, both male and female - People who have been diagnosed with knee osteoarthritis (OA) in one or both knees - People whose knee osteoarthritis has been graded as Grade II or Grade III on a standard medical imaging scale called the Kellgren...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07397806 · Steadman Philippon Research Institute Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2027
🇺🇸 US

**Who might be able to join this trial:** - People between the ages of 40 and 85 years old - People who are able to walk around both at home and in the community - People who have been diagnosed with knee osteoarthritis in one or both knees, confirmed by imaging at a moderate to severe level (Kellgren-Lawrence grade I...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07401719 · Lahore University of Biological and Applied Sciences Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 12 June 2026
🇵🇰 PK

Who might be able to join this trial: - You are between 45 and 60 years old - You are male or female with a confirmed diagnosis of Grade II hip osteoarthritis - You have been experiencing hip pain for more than 6 months Who may not be able to join: - You have a heart condition or cardiac disorder - You have other curr...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07402408 · Riphah International University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 October 2026
🇵🇰 PK

Who might be able to join this trial: - People between the ages of 40 and 60 years old - People experiencing pain rated at 3 or higher on a standard 0–10 pain scale - People whose knee movement is limited to 100 degrees of bending or less, and who cannot fully straighten their knee (confirm with trial site) - People wh...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07404891 · Union Hospital, Tongji Medical College, Huazhong University of Science... Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 July 2026
🇨🇳 CN

**Who might be able to join this trial:** - You are between 50 and 75 years old (any gender) - Your body weight falls within a healthy-to-moderately-overweight range (BMI between 18 and 35) - You have been diagnosed with knee osteoarthritis, including having had recurring knee pain in the past month plus at least two...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07405983 · Keri Medical SA Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2029
🇺🇸 US

Who might be able to join this trial: - People who need their first joint replacement surgery at the base of the thumb (the joint where the thumb meets the wrist) to treat a specific stage of arthritis in that joint (Eaton-Littler Stage II or III — confirm with trial site what stage applies) - People who are 22 years o...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07416357 · Izmir Democracy University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2027
Turkey (Türkiye)

**Who might be able to join this trial:** - You are 45 years of age or older - You have been diagnosed with knee osteoarthritis (wear-and-tear of the knee joint), either through a doctor's examination or an X-ray - Your condition allows you to have an ultrasound scan performed on both knees - You are able to sign a wri...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07417436 · Alanya Alaaddin Keykubat University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2026
Turkey (Türkiye)

Who might be able to join this trial: - People who are 18 years of age or older - People who have been diagnosed with osteoarthritis of the foot and/or ankle by a specialist doctor, confirmed through a physical examination and/or imaging (such as X-rays) - People who have experienced pain in the ankle joint on most day...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07424352 · University of Colorado, Denver Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2028
🇺🇸 US

**Who might be able to join this trial:** *For people with knee osteoarthritis (OA):* - People between 40 and 70 years old who have been diagnosed with moderate knee osteoarthritis confirmed by X-ray (specifically graded as KL Grade 2 or 3) - People who are able to walk on their own, even if a walking aid such as a ca...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07425457 · Attikon Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇬🇷 GR

Who might be able to join this trial: - Adults aged 18 or older who are having a first-time total knee replacement surgery for osteoarthritis (joint wear and tear). - People who are mentally alert and able to rate their own pain and physical function. - People who are willing and able to sign a written consent form agr...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07434011 · Universidad Complutense de Madrid Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 March 2027
🇪🇸 ES

Who might be able to join this trial: - People aged 45 years or older who have knee pain related to activity and morning knee stiffness lasting 30 minutes or less - People who have had knee pain for 3 months or longer - People whose knee pain occurred on most days during the previous month - People whose overall knee p...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07439575 · Bahattin Kemah Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2026
Turkey (Türkiye)

Who might be able to join this trial: - People who are 30 years of age or older - People who are scheduled to have a new total hip or knee replacement for the first time - People who are scheduled to have a revision (repeat) hip or knee replacement surgery for non-infection-related reasons - People whose surgery will b...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07442812 · Haseki Training and Research Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
Turkey (Türkiye)

**Who might be able to join this trial:** - People aged between 50 and 80 years - People who have been diagnosed with primary knee osteoarthritis (wear-and-tear arthritis of the knee, not caused by another condition) - People who are already scheduled to have a first-time total knee replacement as a planned procedure -...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07447323 · Hacettepe University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2026
Turkey (Türkiye)

**Who might be able to join this trial:** **If you have thumb joint arthritis (TMC OA group):** - You are willing to take part voluntarily - An orthopedic specialist has confirmed you have thumb base arthritis using an X-ray (at any stage of the condition) - You have had thumb symptoms for 6 months or longer - You are...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07449403 · Poznan University of Medical Sciences Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2026
🇵🇱 PL

Who might be able to join this trial: - People classified as ASA physical status I, II, or III (a standard medical rating used by anaesthetists to describe overall health — confirm with trial site if unsure which category applies) - People aged between 65 and 100 years old - People scheduled to have hip replacement sur...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07449468 · Poznan University of Medical Sciences Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2027
🇵🇱 PL

**Who might be able to join this trial:** - People aged 75 years or older - People who are scheduled for a planned (non-emergency), first-time total hip replacement surgery - People whose surgery is planned to use spinal anaesthesia (numbing from the waist down) - People classified as having a moderate level of pre-exi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07458360 · Konya Meram State Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 5 June 2026
Turkey (Türkiye)

Who might be able to join this trial: - People aged 18 or older - People who are scheduled to have a total hip replacement surgery using spinal anaesthesia (a type of numbing injection in the lower back) - People whose general health falls within a certain acceptable range as rated by anaesthesia guidelines (a standard...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07464080 · Ottawa Hospital Research Institute Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇨🇦 CA

Who might be able to join this trial: - You are a man or woman aged 18 years or older - You are having a total knee replacement for the first time (not a repeat procedure) - You have been diagnosed with osteoarthritis, inflammatory arthritis (such as rheumatoid arthritis), or a condition where bone tissue in the knee h...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07465484 · I.M. Sechenov First Moscow State Medical University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 August 2027
🇷🇺 RU

Who might be able to join this trial: - Adults aged 18 or older who have been diagnosed with moderate to severe knee osteoarthritis (grade 3 or 4 on a standard medical scale) and report a pain level of 5 or higher out of 10. - People whose leg alignment shows an inward bowing of the knee beyond a certain angle (sometim...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07468734 · German International University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 November 2026
🇪🇬 EG

Who might be able to join this trial: - You are 40 years of age or older and have been diagnosed with chronic knee osteoarthritis confirmed by both a doctor's examination and imaging (such as an X-ray), at a moderate stage (confirm with trial site). - Both men and women are welcome to apply. - You have had ongoing knee...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07472088 · University of Kansas Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2026
🇺🇸 US

Who might be able to join this trial: - Adults aged 18 or older - People who have knee pain that falls into one of two categories: pain only at the front of the knee, or knee osteoarthritis pain that may be anywhere in the knee (including the front) Who may not be able to join: - People who have had both knees fully r...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07473414 · Nantes University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 26 May 2027
🇫🇷 FR

Who might be able to join this trial: - People who have been diagnosed with early-stage osteoarthritis of the knee, based on specific scores from a knee health questionnaire (called the KOOS), a physical examination finding of joint tenderness or a grating/crackling sensation in the knee, and a knee X-ray result within...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07474896 · Poznan University of Medical Sciences Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2027
🇵🇱 PL

Who might be able to join this trial: - People who are 65 years of age or older - People who are scheduled for planned (non-emergency) shoulder surgery - People whose overall health status has been assessed by a doctor as fitting within a certain range of fitness for surgery (classified as ASA I, II, or III — confirm w...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07481461 · Universitaire Ziekenhuizen KU Leuven Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2030
🇧🇪 BE

Who might be able to join this trial: - People who have given their voluntary written agreement to participate (or whose legal representative has done so) before any screening takes place. - People who have ongoing, long-term symptoms of early-stage knee osteoarthritis. - People who have a lower limb alignment problem...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07482332 · Cumhuriyet University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 August 2026
Turkey (Türkiye)

Who might be able to join this trial: - People who have been diagnosed with knee osteoarthritis graded as Kellgren-Lawrence level 2 or 3 (a specific measure of joint wear seen on imaging) - People who are female and between the ages of 40 and 65 - People who are participating voluntarily Who may not be able to join: -...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07484529 · Riphah International University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2026
🇵🇰 PK

Who might be able to join this trial: - People aged between 40 and 65 years old - People who have been diagnosed with osteoarthritis in both knees, according to a specific classification system used by rheumatology specialists, for at least 1 year - People whose knee osteoarthritis has been graded as a 2 or 3 on the Ke...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07493239 · Lesaffre International Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 5 October 2026
🇺🇸 US

Who might be able to join this trial: - People aged 45 years or older. - People with a body mass index (a measure of body weight relative to height) between 18 and 35. - People who have a known diagnosis of Knee Osteoarthritis and have experienced mobility difficulties and joint discomfort related to it for at least 6...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07496203 · Hacettepe University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 20 March 2026
Turkey (Türkiye)

Who might be able to join this trial: - People who have been diagnosed with knee osteoarthritis using a standard set of medical diagnostic guidelines known as the ACR criteria - People whose knee osteoarthritis has been classified as stage 2 or 3 on a standard X-ray grading system called the Kellgren-Lawrence scale - P...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07507175 · Cairo University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 July 2026
🇪🇬 EG

**Who might be able to join this trial:** - People between 45 and 55 years of age - People with a Body Mass Index (a measure of body weight relative to height) of 35 or below - People who have been diagnosed with primary knee osteoarthritis (wear-and-tear knee joint disease) based on recognised classification standard...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07513415 · Endovision Co., Ltd. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2027
🇰🇷 KR

**Who might be able to join this trial:** - You are a man or woman aged 40 to 79 years old at the time of signing the consent form. - You have been diagnosed with knee osteoarthritis (a condition where the cartilage in the knee wears down) according to standard medical guidelines, either at or within 24 weeks before y...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07520721 · Spaarne Gasthuis Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 July 2035
🇳🇱 NL

Who might be able to join this trial: - People of any gender who are 18 years of age or older - People with a life expectancy of more than 5 years - People who have had painful shoulder osteoarthritis for more than 1 year and have already tried non-surgical treatments without sufficient relief - People whose doctors ha...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07533188 · Singapore General Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 14 October 2027
🇸🇬 SG

**Who might be able to join this trial:** - You are having a knee replacement surgery that uses a robotic-assisted system called VELYS. - You have been diagnosed with knee osteoarthritis (wear-and-tear of the knee joint) that requires surgery. - You are able to give your written agreement to take part in the study. - Y...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07537153 · Northwestern University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 10 April 2028
🇺🇸 US

**Who might be able to join this trial:** - People aged between 40 and 80 years old - People with mild-to-moderate knee osteoarthritis confirmed by X-ray results showing a specific severity level (Kellgren-Lawrence grade 2 or 3) - People who report their knee pain as at least 5 out of 10 on a standard pain scale - Peo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07542808 · Cellcolabs Clinical SPV Limited Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 27 September 2027
🇦🇪 AE

**Who might be able to join this trial:** - People who are willing and able to give written consent and follow all the steps required by the study. - People who are 18 years of age or older at the time of signing the consent form. - People who have been diagnosed with knee osteoarthritis according to American College...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07544823 · The First Affiliated Hospital of Xinxiang Medical College Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2026
🇨🇳 CN

Who might be able to join this trial: - People who are between 40 and 70 years old (inclusive) - People who have had joint pain or stiffness lasting at least 3 months - People who are willing to take part and have signed a consent form Who may not be able to join: - People who have other serious joint conditions, such...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07551245 · Erbil Polytechnic University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 January 2027
Iraq

Who might be able to join this trial: - People who have been diagnosed with knee osteoarthritis (a condition where the knee joint breaks down over time), confirmed by a doctor using X-rays or MRI scans showing specific signs of joint damage. - Adults between the ages of 40 and 75 years. - People who are willing to give...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07558590 · FX Solutions Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 31 December 2036
🇫🇷 FR Monaco

Who might be able to join this trial: - People who have a medical reason to need a partial or total shoulder replacement surgery using one of the FX Shoulder Solutions shoulder implant systems, as directed by their surgeon - People who are 18 years of age or older - People who are covered by a social security or health...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07566507 · Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇮🇹 IT

Who might be able to join this trial: - People who have arthritis at the base of the thumb (where the thumb meets the wrist) that is classified as early-stage (Stage 1 or 2 on a standard X-ray rating scale), confirmed by an X-ray taken within the last 6 months - People who have been experiencing symptoms for at least 6...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07569549 · Uppsala University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2030
🇸🇪 SE

Who might be able to join this trial: - People aged between 40 and 80 years old at the time of joining - People who have been diagnosed with arthritis at the base of the thumb, graded as stage 1, 2, or 3 on a standard medical scale (known as the Eaton-Littler classification) - People who experience pain at rest or pain...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07569848 · Istituto Ortopedico Rizzoli Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 11 February 2028
🇮🇹 IT

**Who might be able to join this trial:** - Adults between 35 and 75 years of age (male or female) - People who have a condition affecting the ankle joint (where the shin bone meets the ankle bone) that doctors have determined requires surgery to replace the joint with a prosthetic (artificial) implant - People with s...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07574762 · Groupe Hospitalier Diaconesses Croix Saint-Simon Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2028
🇫🇷 FR

Who might be able to join this trial: - People who are willing and able to sign a consent form agreeing to take part, as required by regulations - People aged 18 or older, male or female - People who are scheduled to have a full knee replacement for the first time due to osteoarthritis (joint wear and tear) - People wh...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07575425 · Gaziler Physical Medicine and Rehabilitation Education and Research Ho... Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2026
Turkey (Türkiye)

**Who might be able to join this trial:** - You are between 45 and 65 years old - You have been diagnosed with knee osteoarthritis rated as a moderate level of severity (specifically Kellgren-Lawrence grade 2 or 3 — confirm with trial site if unsure of your grade) - You are willing to take part in the study voluntarily...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07575555 · Izmir Democracy University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 July 2027
Turkey (Türkiye)

**Who might be able to join this trial:** - Women between the ages of 30 and 65 - People who have been diagnosed with knee osteoarthritis through both a physical examination and imaging (such as an X-ray or scan) - People who have agreed to take part in the study *For Group 1 — knee osteoarthritis with lipedema:* - P...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07580222 · VA Office of Research and Development Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2027
🇺🇸 US

Who might be able to join this trial: - People who are veterans or non-veterans (both are welcome) - People of any gender (male or female) - People who have been diagnosed with early-stage knee osteoarthritis - People who previously took part in a specific study called "Precision Assessment of Platelet Rich Plasma for...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07580716 · Enlivex Therapeutics Ltd. Phase 2 · 3 countries Recruiting
Recruiting Phase 2 Est. completion 1 February 2027
🇩🇰 DK🇵🇱 PL🇺🇸 US

**Who might be able to join this trial:** - People aged 64 years or older - People who have been diagnosed with knee osteoarthritis (OA) affecting the joint between the thigh bone and shin bone (the main knee joint) - People whose knee osteoarthritis has been confirmed by X-ray, showing a moderate level of joint chang...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07581470 · Poznan University of Medical Sciences Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2027
🇵🇱 PL

Who might be able to join this trial: - People who are 18 years of age or older - People who are scheduled for a planned (non-emergency) total hip replacement surgery - People whose surgical plan includes a type of nerve-blocking pain relief technique called a PENG block - People who fall within a general health rating...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07595718 · Jae Yong Jeon, MD Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 October 2026
🇰🇷 KR

Who might be able to join this trial: - You are an adult between 30 and 60 years old. - You have been formally diagnosed with at least one of the following conditions: type 2 diabetes, breast cancer, heart disease, osteoarthritis, or low back pain (this applies to the "disease group"). - Alternatively, you have never b...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07598474 · University of Faisalabad Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 19 July 2026
🇵🇰 PK

**Who might be able to join this trial:** - People who have been diagnosed with Grade III knee osteoarthritis (a specific level of knee joint wear and tear), confirmed by an X-ray taken within the past 12 months or a new one taken for this trial - People whose knee pain has a nerve-related component, confirmed by a sh...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07603973 · Diakonhjemmet Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2028
🇳🇴 NO

Who might be able to join this trial: - Men and women over the age of 50 who have been referred to specialist healthcare for knee osteoarthritis (a condition where the cartilage in the knee breaks down) Who may not be able to join: - People who have already had a joint replacement in the affected knee, or where a revi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07618403 · Gazi University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2027
Turkey (Türkiye)

Who might be able to join this trial: - You are willing and agree to take part in the study - You are over 50 years old - You have been diagnosed with knee osteoarthritis (knee joint wear and tear) confirmed by a doctor and imaging (such as an X-ray) - Your knee osteoarthritis has been rated as moderate to severe using...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07625150 · University of California, San Francisco Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2028
🇺🇸 US

**Who might be able to join this trial:** - Adults who are able to make their own decision to take part and provide consent - People who are able to perform 25 single-leg squats - People who have not had a traumatic knee injury or knee surgery since their last visit in the related parent study (IRB #21-34763) - People...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07630337 · Hospital Italiano de Buenos Aires Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2027
🇦🇷 AR

Who might be able to join this trial: - People who are between 60 and 80 years old - People who are scheduled to have a first-time total knee replacement surgery due to knee osteoarthritis (joint wear and tear) - People who are able to understand what the study involves and are willing to sign a consent form Who may n...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07637682 · Tanta University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2026
🇪🇬 EG

**Who might be able to join this trial:** - Adults aged between 30 and 70 years old who have been diagnosed by a doctor with moderate to severe knee osteoarthritis (a condition where the joint wears down over time) and who experience knee pain - People for whom the cost of joint injections or a nerve-treatment procedur...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07645989 · MuseCell Innovations Pte LTD Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 1 July 2031
🇲🇽 MX🇺🇸 US

**Who might be able to join this trial:** - People who have received Dezawa MuseCells® as part of their normal medical care (not as part of a research study) - People who are able to give their agreement to take part, or who have an authorised representative who can do so on their behalf - People who are willing to com...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07651462 · Charite University, Berlin, Germany Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2026
🇩🇪 DE

Who might be able to join this trial: - Adults between 18 and 75 years old (inclusive) - People who are already scheduled to have a planned (non-emergency) first-time total hip replacement surgery - People who are able and willing to sign a written consent form agreeing to take part - People who are able to follow a 20...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07651735 · TIPMED Medical Device Manufacturing Ltd. Co. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2028
Turkey (Türkiye)

Who might be able to join this trial: - People who are 18 years of age or older - Both men and women are eligible to participate - People who have had a primary hip replacement surgery (either full or partial) for any medical reason - People whose hip replacement surgery used the Tipmed™ Primary Hip Prosthesis System c...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07653841 · Ibadat International University, Islamabad Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 September 2026
🇵🇰 PK

Who might be able to join this trial: - Men and women between the ages of 40 and 70 years old - People who have been diagnosed with knee osteoarthritis rated as Grade I, II, or III on a standard medical scale (called the Kellgren-Lawrence classification) - People who have had ongoing knee pain lasting 3 months or longe...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07664371 · Tanta University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2026
🇪🇬 EG

**Who might be able to join this trial:** - Adults between 30 and 70 years old who have been diagnosed with knee osteoarthritis that has not responded well to treatment, and who are experiencing knee pain - People for whom the cost of joint injections is a barrier to receiving them - People who have already tried at le...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07666347 · Tanta University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇪🇬 EG

**Who might be able to join this trial:** - You are 50 years of age or older - You are of any gender - You have been diagnosed with long-term knee osteoarthritis (a condition where the cartilage in the knee wears down over time), confirmed using recognised medical guidelines - Your knee osteoarthritis has been rated as...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07673328 · University of Michigan Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 March 2030
🇺🇸 US

Who might be able to join this trial: **For generally healthy adults without knee problems:** - People aged between 18 and 65 years - People who weigh less than 300 lbs - People with a BMI under 40 **For people with knee osteoarthritis:** - People aged between 30 and 85 years - People who have been medically diagnose...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07678996 · Kayseri City Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 November 2026
Turkey (Türkiye)

Who might be able to join this trial: - You are between 40 and 75 years old and have been diagnosed with knee osteoarthritis by a doctor using recognized medical guidelines. - Your knee osteoarthritis has been rated as moderate in severity based on X-ray results (confirm with trial site). - You have had ongoing knee pa...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07695168 · National Taiwan University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇹🇼 TW

Who might be able to join this trial: **Group A – Healthy Adults:** - People between 20 and 80 years of age - People who have no knee discomfort, such as knee pain or muscle weakness **Group B – People with Knee Osteoarthritis:** - People between 50 and 80 years of age - People who have been diagnosed with knee osteo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07701174 · University of Lahore Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 25 August 2026
🇵🇰 PK

Who might be able to join this trial: - People who are between 40 and 60 years old, of any gender - People who have had pain in one knee and a grinding or crackling sensation in that knee for at least 6 months, particularly when going up or down stairs or slopes - People whose knee X-rays show a certain level of joint...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07706569 · Antalya Training and Research Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 August 2026
Turkey (Türkiye)

**Who might be able to join this trial:** - People who have been diagnosed with knee osteoarthritis based on American College of Rheumatology (ACR) standards - People whose knee osteoarthritis has been graded as moderate to severe (Grade 2, 3, or 4) using a standard X-ray scoring system called the Kellgren-Lawrence sca...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Advocacy and support in Australia

Organisations that can offer information, support, or connection for Osteoarthritis. Where more than one is listed, they serve different needs or regions, so choose whichever fits your situation.

Arthritis Australia is the national body for osteoarthritis, among the arthritis conditions it covers.

This is a starting point, not medical advice or an endorsement. Contact details change; search the organisation name to find its current website.